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Abhijit Deb Roy, PhD
University of Connecticut, 2018
Bone remodeling is critical for maintenance of bone health and requires a
balance of bone resorption by osteoclasts followed with formation by osteoblasts.
These opposing activities are spatially and temporally segregated and
coordinated on the bone surface. Chemoattraction between osteoclasts and
osteoblasts has been extensively investigated and has been proposed to direct
osteoblasts to the site of bone resorption. However, the mechanism by which
osteoclasts and osteoblasts are spatially segregated on the bone surface
remains unknown. In this thesis, I demonstrate that osteoclasts induce contact
inhibition of locomotion in migrating osteoblasts, which may enable spatial
segregation of these cells. I identify Semaphorin 4D, expressed on the surface of
osteoclasts, and its receptor Plexin-B1, expressed by osteoblasts, to be critical
for the induction of contact inhibition of locomotion. I developed an optogenetic
tool to initiate Plexin-B1 signaling using blue light, named optoPlexin. Localized
stimulation of optoPlexin in subcellular regions elucidated spatial and temporal
dynamics of signaling pathways involved in mediating contact inhibition of
locomotion. In addition, I used optoPlexin to develop a novel protein-protein
interaction assay in live cells, which revealed a previously unknown role of the
RGS-like domain of PDZ-RhoGEF in mediating recruitment by Plexin-B1.
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This thesis provides new understanding of the interactions between osteoclasts
and osteoblasts during bone remodeling, illustrates the impact of localized
Semaphorin 4D-Plexin-B1 stimulation in migrating osteoblasts, and provides new
information on the molecular mechanism of Plexin-B1 signaling. The
observations on spatial regulation of signaling pathways in cells undergoing
contact inhibition of locomotion are pertinent to understanding the molecular
pathways mediating cell repolarization. Furthermore, the novel optogenetic
approach utilized to locally stimulate Plexin-B1 may be extended to other plexins,
and potentially to other repulsive-guidance molecules. Thus, this work presents
a significant advance not only in the field of bone biology and semaphorin-plexin
signaling, but cell biology in general.
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CHAPTER I
Introduction

Bone and its remodeling
Bone is a rigid mineralized connective tissue found in vertebrates. It
provides structure, shape and support to the animal body, protects internal
organs and enables fast and complex movements of animal limbs. In addition,
bones act as a reservoir for minerals and growth factors, provides a site for
maintenance of stem cells and produces different types of cells including red and
white blood cells. In humans, the load bearing long bones are composed of two
morphologically distinct types: cortical and trabecular bones. Cortical bones are
the dense matrix on the cortex of most bones and provide strength by being
resistant to bending and torsion. Trabecular or cancellous bone form a
honeycomb-like network inside bones. Trabecular bones are weaker and more
flexible than cortical bones, and may act as shock absorbers. During movement
and other load-bearing activities, trabecular bone may undergo localized
damage. Unless remedied, such damage may accumulate and compromise
skeletal integrity over time. Bone remodeling, a process by which older bone is
replaced by new bone plays a critical role in the restoration of bone strength and
maintenance of skeletal integrity1–3. Bone remodeling primarily involves three
types of cells: osteoclasts, osteoblasts and osteocytes.
Remodeling is initiated by resorption of bone by osteoclasts, followed by
deposition of bone matrix by osteoblasts. Osteocytes may play a role in directing
osteoclasts to sites of bone resorption4. Resorption and formation of bone matrix
are quantitatively coupled so that the amount of bone resorbed is replaced by
deposition3. Imbalances in this coupling can lead to pathological states, the most
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prominent being osteoporosis marked by a loss of bone mineral density and
weaker bones making patients prone to fractures. During remodeling, bone
resorption in damaged trabeculae are spatially and temporally discrete events,
for proper remodeling it is important that the consequent bone deposition occurs
at the site of resorption after the resorption is completed and the active
osteoclasts are no longer present. Such intricate spatiotemporal orchestration of
osteoclast and osteoblast activities involves many ‘coupling factors’ that regulate
their migration and differentiation.
Fracture healing is distinct from bone remodeling. After fracture, there is a
rapid inflammatory response, followed by proliferation of fibroblasts that form a
loose connective tissue called granulation tissue. Osteoclasts migrate to the site
and resorb bone fragments and prepare the broken bone ends for healing. The
cells in the periosteum, which is the outer layer of bones, proliferate and
differentiate into chondroblasts and forms collagen rich ‘hyaline cartilage’; and
osteoblasts, which lay down ‘woven bone’: a form of bone matrix with
disorganized collagen fibers. As these new collagen matrices close the gap
produced by the fracture, over time they are replaced by more organized lamellar
bone matrix and formation of trabecular bone. Finally, over a significantly longer
time scale, these trabecular bones undergo remodeling to form compact bones
and the bone is healed to a state close to the pre-fracture form5.
This section will provide a brief overview of the cells involved in bone
remodeling, the aforementioned coupling factors and regulation of osteoblastic
migration to the site of resorption.
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Bone cells
Osteoclasts: Osteoclasts are large multinucleated cells of hematopoetic origin
that degrade bone. Osteoclasts are formed by fusion of mononuclear
macrophage lineage cells. Receptor activator of nuclear factor kappa ligand
(RANKL), which is expressed by osteoblastic lineage cells, is critical for
osteoclastogenesis2,6. Macrophages express RANK, which is activated by
RANKL from osteoblast-lineage cells. RANKL is generally thought to be plasma
membrane bound, indicating that cell-cell contact between macrophages and
osteoblast-lineage cells are critical for osteoclastogenesis (Figure 1a).
Furthermore, osteoblast-lineage cells also express osteoprotegerin (OPG), which
acts as a decoy receptor for RANKL, thus inhibiting osteoclastogenesis6.
Osteoclasts migrate to specific sites on the bone surface and initiate resorption
by forming an actin-rich sealing zone and secreting protons to efficiently dissolve
the mineralized hydroxyapatite component of bone, followed by degradation of
the collagen matrix by metalloproteases and cathepsins1. Uncontrolled increase
in osteoclast numbers or activity is associated with osteoporosis and rheumatoid
arthritis, whereas defects in osteoclast resorption can cause osteopetrosis. One
common strategy to combat osteoporosis is bisphosphonate treatment, which
acts by decreasing osteoclast survival and action7. Long term decreases in
osteoclast viability, and thus severe decreases in bone resorption effectively
halts remodeling. Such lack of remodeling leads to a ‘frozen bone’ syndrome,
where damages accumulate in the skeleton, impairing bone integrity and
increasing the probability of failure.

4

a)

RANK
RANKL

BMM

osteoclast
osteoblast

bone
osteocytes

soluble chemoattractants
PDGF, TGF-β1, S1P etc.

b)
direction of migration

osteoclast

osteoblast

site of resorption

c)

osteoclast

osteoblast
Figure 1. Interactions between bone cells during remodeling. a) Interactions
between pre-osteoclasts and osteoblastic lineage cells during RANKL mediated
osteoclastogenesis. b) Chemotaxis of osteoblasts towards the site of resorption. c)
Repulsion of osteoblasts upon contact with osteoclasts
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Osteoblasts and osteocytes: Osteoblasts are mesenchymal lineage
cells that synthesize bone. They are generally spindle shaped or polygonal.
During bone remodeling, osteoblasts restore the bone removed by osteoclasts by
the same amount in the same region of resorption, and thus regulate bone
integrity. Pre-osteoblasts are thought to migrate to site of resorption after the
osteoclasts have prepared the substrate and moved away, differentiate and
deposit bone matrix. Over time this matrix gets mineralized bringing the bone
back to its previous strength, marking the end of the remodeling cycle1. In the
course of matrix deposition, some of the osteoblasts get entrapped in the matrix
and terminally differentiate into osteocytes. Osteocytes have a stellate shape and
are non-motile. They form intricate connected network spanning the bone matrix
through long extended cytoplasmic processes in the bone canaliculi. Osteocytes
have been proposed to respond to mechanical loading to coordinate bone
remodeling, although the molecular mechanisms involved in such signaling
remains elusive. In-vitro assays with cultivating osteocytic cell lines in matrigel
have demonstrated their capability of exchanging cytoplasmic material, and may
be one way by which they secrete cytokines. In addition, recently, osteocytes
have been demonstrated to express RANKL and proposed to support, if not
predominantly mediate, osteoclastogenesis4. However, the mechanism by which
macrophages may access membrane-bound RANKL in osteocytes embedded in
bone matrix is not well understood.
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Coupling factors in bone remodeling
The osteoblastic cells interact with osteoclast precursors and osteoclasts
at multiple stages during the bone remodeling process. Bone remodeling is
initiated by osteoclastic resorption. Osteoclastogenesis is regulated by the ratio
of RANKL and OPG expressed by osteoblast lineage cells. Accounting for the
highly localized nature of osteoclastic resorption, spatial and temporal regulation
of osteoblastic migration to the site of resorption is critical for proper bone
remodeling. The coupling of osteoblasts to osteoclasts may be realized through
multiple ways. During bone matrix formation, osteoblasts deposit growth factors
such as PDGF, TGF-β, BMP-2 and IGFs, which are released during osteoclastic
resorption and may promote osteoblast migration3,8–10. Additionally, osteoclasts
also secrete factors such as S1P, BMP-6, CTHRC1, and cardiotropin-1 that may
promote osteoblast migration to the site of resorption3,11,12 (Figure 1b). While the
focus has been on coupling factors expressed or regulated by either osteoclasts
or osteoblasts, the bone microenvironment contains many different types of cells,
which may also secrete some of these factors, thus making the coordination of
bone resorption and formation much more nuanced and thus, more complex.
Finally, changes in the topography of bone surface after osteoclastic action may
also play a role in mediating osteoblast migration and function13,14.
Osteoblasts respond to chemoattractants released to locate the site of
active resorption. Migration of osteoblastic cells to the site of resorption
presumably happens in different phases: recruitment of osteoblastic progenitors
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to the bone surface and migration of pre-osteoblasts to the specific site of
resorption. Resorption is initiated around 4-8 weeks prior to bone deposition
phase. Since migratory factors released from the bone matrix during the early
stages of resorption would presumably diffuse away during this period, it is likely
that these factors recruit of osteoblast progenitors to the bone surface. Once on
the bone surface, factors released from the matrix as well as those secreted by
osteoclasts may guide them to the appropriate site. Since osteoclasts and
osteoblasts are not usually observed the same space on bone surface, we may
reason that osteoblasts occupy the site of resorption only after the osteoclasts
have migrated away or undergone apoptosis. In the absence of active
osteoclasts, there is no obvious source for chemoattractants, and how the preosteoblasts identify the exact location of resorption is not well understood.
Haptotaxis or durotaxis, or a combination of both may play an important role in
directing pre-osteoblasts to the resorption pits, but that requires the preosteoblasts to be present on the bone surface prior to completion of resorption.
Additionally, osteoclasts and osteoblasts have completely opposing functions,
and express factors that inhibit one another’s differentiation and activity. Thus,
ideally, the osteoblast progenitors should be recruited to the bone surface, and
migrate towards but not occupy the site of resorption until the osteoclasts have
completed resorption. Indeed in vivo, osteoblasts and osteoclasts are observed
spatially segregated on the bone surface and rarely in contact with one
another15,16. In the presence of only a chemotactic gradient, osteoclasts and
osteoblasts should be clustered together. Thus, the current model of bone
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remodeling does not explain segregation of osteoclasts and osteoblasts on the
bone surface and fails to give a complete picture of spatial regulation of bone
remodeling. A combination of chemotaxis and repulsion upon contact between
the two cell types may be explain how pre-osteoblasts may be recruited to the
general region of resorption and yet be kept away from sites with active
osteoclasts (Figure 1c). Although repulsion-like behavior occurring between
osteoblasts and osteoclastic cells has been reported intermittently17,18, such
behavior and the pertinent signaling mechanisms have not been examined.
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Repulsion between cells
Directional cell migration is critical for proper embryonic development as well
tissue homeostasis in adult animals, defects in which may cause disease states.
Directionality in migration may be achieved by attractive or repulsive cues,
respectively guiding cells towards or away from a source. Chemoattractive
factors and chemotaxis in cells have been extensively studied across many
systems. Chemotaxis is achieved by polarizing a migrating cell to promote and
stabilize protrusions towards and inhibiting protrusions away from the target.
Conversely, repulsion may be elicited by destabilizing protrusions towards the
target and inducing repolarization of the direction of migration. In addition,
repulsion between cells may occur in response to soluble factors or require
contact between cells. There were also some early reports of long distance
repulsion between cells through electrostatic forces19,20; although such
responses may not be of particular physiological import.
Repulsion in response to soluble factors was first reported in a response
of bacterial cells by antimicrobial agents or factors released by neutrophils.
Soluble repulsive factors may act by countering effects of chemoattractants;
however, repulsion is not mere inhibition of chemotaxis. Repulsive response in
eukaryotic cells in response to soluble factors was first reported and has been
extensively studied in neuronal guidance21. Repulsive factors in neuronal
development were experimentally studied in the context of axon growth cone
collapse22–24, which were extended to neurite retractions and collapse of
protrusions in other cells. In particular Netrins, ephrins, semaphorins and Slit
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have been have been proposed to play key roles in axonal repulsion based upon
collapse assays utilizing solubilized ligands22–28. It is noteworthy that Netrin,
ephrin and semaphorin families have both secreted and plasma membrane
bound members. Additionally, some of these plasma membrane bound ligands
may undergo proteolytic cleavage and act as soluble repulsive guidance cues.
More recently, immune cells have been reported to undergo migration down a
gradient of growth factors. This phenomenon has been variously called fugetaxis,
reverse chemotaxis and chemorepulsion. In particular SDF-1, S1P and IL-8 have
been implicated in repulsion of immune cells29–32. Additionally, Slit has also been
reported to inhibit response to chemoattractants33. Chemorepulsion of immune
cells has been proposed to mediate emigration of T-cells from the thymus34, and
may be utilized by viruses and cancer cells to avoid detection by the immune
system31,35. Conversely, chemorepulsion may be utilized to reduce rejection in
organ transplants by utilizing cells expressing repulsive factors in allografts.
Repulsion between cells was first reported to occur between fibroblasts
after contact, wherein cells ceased to persist in their direction of motion after
contact with another cell36. Unlike chemorepulsion mediated by soluble factors
released into the extracellular environment, repulsion after contact is arguably
mediated by membrane bound factors and thus may only be effective when two
cells, expressing the appropriate ligand-receptor pair come in contact. This work
is mainly focused on contact repulsion or contact inhibition of locomotion (CIL),
which is discussed in greater details in the following section.

11

Contact inhibition of locomotion
Contact inhibition of locomotion (CIL) is the phenomenon where cells
migrate away from one another following cell-cell contact. Abercrombie and
Heaysman first reported such behavior in 1953 from their observation of
migratory behavior of chick fibroblasts in vitro. Abercrombie coined the term
‘contact inhibition’ to describe their observation of ‘directional prohibition’ of cell
migration upon contact with other cells36. While significant in its own regard,
investigation into CIL enabled probing into the fundamental questions of cell
migration such as persistence, maintenance and changes in front and back
polarity etc. Shortly after two decades of investigation into its various facets, the
term ‘contact inhibition’ in context of cell motility as well as investigation into
repulsion between cells fell out of favour. This was partly due to an increased
interest in ‘contact inhibition of proliferation’, coined in mid 1960s, which had
been gaining traction in the scientific community trying to identify differences
between ‘normal’ and cancer cells grown in culture. Additionally, the
physiological relevance of CIL was not obvious, and the events that CIL was
composed of, such as directional cell migration, cell-cell contact, front and back
polarity of migrating cells were being studied independently37. Furthermore, some
groups that were studying repulsion between cells were using the term ‘contact
repulsion’ to avoid confusion with contact inhibition of proliferation. Recently, the
term CIL has come back in vogue in part due to the efforts of Roberto Mayor,
whose work focuses on the impact of CIL on directional migration of neural crest
cells38–40. There is considerable variation in the phenomena that are defined or
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Figure 2. Contact inhibition of locomotion (CIL). (a) absence of CIL, (b) type
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described as CIL, perhaps due to the originally broad and relatively vague
definition of CIL as ‘cessation of a cell continuing to migrate in the same direction
after contact with another cell’ covered, and still covers a wide range of cellular
behavior. Indeed, it may be easier to describe what CIL is not than what it is.
When contact with another cell does not alter the direction or magnitude of
motility of a migrating cell, it has not experienced CIL (Figure 2a).
Types of contact inhibition of locomotion
In an effort to define the different responses cells undergo that may be
ascribed to CIL, it has been proposed to be classified into as many as six types.
Abercrombie had classified CIL into two types: type I (Figure 2a) involved
contraction of the leading edge at the site of contact, repolarization and migration
away from the site of contact; and type II (Figure 2b), which involved inability of a
cell to move over or across another cell and may involve cessation of movement
or gliding past the cell in contact37,41. From a molecular signaling perspective,
type I CIL may be described to involve repolarization induced by signaling
pathways initiated upon contact, whereas type II may be described as a cell
migrating away from or around a physical barrier to motility. Although superficially
distinct, type I and type II may not be entirely independent of one another since
physical contact between two cells may initiate signaling depending on changes
in mechanical forces or membrane tension experienced by the cells or the nature
of the substrate available, and the extracellular environment may modulate the
response of repolarization signaling initiated upon contact. It is perhaps easier to
define type I CIL as change in migratory behavior mediated by signaling across
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two cells upon contact through plasma membrane localized ligand-receptor
complexes. CIL may be further categorized as homotypic: between similar cells,
or heterotypic: between different types of cells. Contact between cells of similar
of different types can yield completely different responses in the same cells. This
work primarily pertains to type I heterotypic CIL between osteoblasts and
osteoclasts, and is discussed in details in chapter II.
Assays to study and quantify contact inhibition of locomotion
Regardless of the categories and classifications, it is worth remembering
that CIL is neither discrete nor uniform behavior. It ranges the gamut of cessation
of motility, moving around another cell or a complete reversal of direction of
migration. Such wide range of responses makes it particularly tricky to decide
whether a cellular response is CIL or not. To account for the diverse responses
that may be CIL, researchers have utilized different experimental assays and
analytical approaches to qualitatively and quantitatively study CIL37,42–44. Some of
them are briefly discussed below.
Mixing assay: Two different groups of cells or tissue explants are placed
next to one another, and the degree of overlap between the two groups of cells
after a certain period of time is measured. Presence of CIL will decrease the
degree of overlap or mixing of the two groups. The difference in distance
traversed by cells when placed next to the other group versus alone, or the
degree of mixing indicates the impact of CIL on their spreading (Figure 3a).
Radial outgrowth: A group of cells that undergo homotypic CIL will
spread radially outwards away from their neighbors. This behavior may be
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Figure 3. Assays to evaluate CIL. (a) Mixing assay, (b) radial outgrowth assay, (c) one
dimensional kinematics post collision and (d) cell polarization map after collision.
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utilized to assess CIL in cells by measuring the spread of cells from a relatively
confluent culture or tissue explant (Figure 3b). This assay is, of course, not useful
for heterotypic CIL, or if the cells predominantly move collectively.
Cell-cell contact kinematics: Observing changes in the trajectory of cells
coming in contact with another can be utilized to assess CIL. In the absence of
CIL, contact with another cell will have minimal impact of the migrating cells,
where if CIL occurs, the direction of migration of the cells should be altered
significantly. Measurements of such changes in direction upon contact should be
compared against free moving cells to account for random switches in direction
in freely moving cells. As an extension, some groups have utilized patterned
substrates to restrict cell movement in a line42,45, which simplifies quantification of
CIL (Figure 3c). However, restricting movement in a single line may significantly
alter cell behavior by changing the threshold required for change in direction.
Changes in cell morphology and polarity: The basic definition of CIL
pertains to a change in the state of motion of a cell upon contact with another.
Observing contacts between migrating cells can enable identification of changes
in cell morphology and polarity. In particular, a polarity map to identify the
location of new protrusions formed with respect to the site of contact has been
used to qualitatively identify CIL (Figure 3d). This may be particularly useful when
investigating CIL in vivo.
Each of these assays has their pros and cons. In particular, whether these
assays are relevant in assessing cell behavior in a three-dimensional in-vivo
environment remains to be determined. In addition to subjective observation, it is
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useful to quantify cell behavior to distinguish between CIL and lack of it. Different
groups have measured the frequency of protrusion collapse upon contact,
separation between cells and deviation in direction of migration post contact to
quantify CIL. We have quantified CIL between osteoblasts and osteoclasts using
all three approaches, which are described in chapter II.
Molecular mechanisms of contact inhibition of locomotion
Type I CIL response in cells may be divided into four events that occur
one after another to orchestrate one seamless response (Figure 4). Obviously,
these events are neither independent of nor separated from one another and
there may be different degrees of overlap depending on context. Nevertheless, it
may be useful to utilize these subjectively defined stages of CIL to delve into the
molecular pathways that regulate CIL.
Cell-cell contact: Type I CIL presumably involves activation of signaling
pathways in the cell through membrane bound molecules on the other cell
(Figure 4a). This would require a relatively stable cell-cell contact. Recent studies
have pointed at the role of cadherins in formation of cell-cell junctions46,47.
Furthermore, other proteins that mediate formation of adherens junctions such as
vinculin, p120, α-catenin and β-catenins have also been reported to play different
roles in CIL37,39,48. However, these proteins are also involved in making stable
cell-cell contacts, and the reason behind the transience of the junctions in CIL is
not well understood. One possibility is the role of different cadherins in organizing
stable versus transient junctions. In particular, E and N-cadherin have been
respectively proposed to mediate stable contacts and repulsion between cells.
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Wnt-Frizzled signaling may be engaged upon cell contact. Furthermore,
engagement of other membrane-bound molecules may modify or over-ride the
nature of cell-cell contacts. In particular repulsive guidance molecules such as
Ephrins and Eph receptors and SLIT-ROBO signaling have been implicated in
mediating CIL between cells37,49,50. In a similar vein, here I have attempted to
demonstrate the role of Semaphorins and Plexins, more specifically Semaphorin
4D and Plexin-B1 in mediating CIL. Aside from cadherins, how much this ligandreceptor coupling may stabilize cell-cell contact is not known. Since the very
nature of CIL implies a relatively short contact between cells, how such ligandreceptor pairs identify these sites of contact is an interesting question. It is
possible that diffusion on the plasma membrane enables accumulation at the site
of contact, which in turn is stable until a critical threshold of repulsive signal is
achieved.
Collapse of protrusions: Cell-cell contact and cessation of protrusions at
the site of contact, in order, are hallmarks of CIL. Members of the Rho family of
small GTPases are well known regulators of front and back polarity in cells. More
specifically, Rac1 and Cdc42 are known to promote actin polymerization and
protrusions, whereas RhoA is generally thought to promote myosin driven
contractility to inhibit protrusions and mediate retractions. In addition,
phosphatidylinositols, which are lipid components of the plasma membrane are
also involved in regulation of protrusions and retractions through cross-talk with
small GTPases. Cessation or collapse of protrusions involves inhibition of Rac1
and/or Cdc42 activities at the leading edge (Figure 4a, 4b). The precise
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mechanism of such inhibition is not well understood, although it is possible that
different pathways may engage different molecules to inhibit Rac1 and Cdc42. NCadherin, PAR3 and Dishevelled have been reported to mediate Rac1 inhibition
in Neural Crest cells39,51–54. Ephrin and Eph receptor mediated CIL may involve
activation of RhoA, which has an inhibitory relationship with Rac1. Although
cross-talk between small GTPases55, in particular that between RhoA and Rac1
(and Cdc42) seem to be consistent across many instances of CIL, the exact
molecular signaling pathways that mediate such crosstalk need further
elaboration.
Repolarization: Inhibition of protrusions at the site of cell-cell contact is
usually followed by increased contraction, converting the former protrusion into a
retraction. Around the same time, a new protrusion is formed away from the site
of contact that causes the cell to repolarize (Figure 4c). It may be speculated that
such repolarization primarily involves spatial reorganization of the factors that
maintain front and back polarity in a migrating cell. RhoA activation appears to
play a critical role in the induction of contractility at the site of contact. Such
contractility may result in increased mechanical tension around the region of
contact, which has been observed in CIL between Drosophila macrophages56. In
addition, RhoA may activate PTEN57, which is a known inhibitor of
phosphoinositide-mediated protrusions. Additionally, increased tension in the
actin cytoskeleton may also induce repolarization of cells through
mechanosensitive signaling pathways, although the precise mechanism of such
repolarization remains to be elucidated. Repolarization of the cell also involves
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reorientation of microtubules away from the site of contact towards the new
protrusions. In Drosophila marcophages, microtubule catastrophe around the site
of cell-cell contact has been observed, but the signaling mechanism involved in
this reorientation is not currently known56. Although simple in concept,
repolarization of a cell involves reorganization of all the essential cytoskeletal
components: actin, microtubules and plasma membrane, and thus potentially
involves a large degree of crosstalk across the pathways that mediate these
different cytoskeletal elements, the precise nature of which is currently not well
understood.
Migration away from the site of contact: Once repolarized, the cells
may continue to migrate away from the site of contact (Figure 4d). While positive
feedback may be involved in maintaining the front and back after repolarization,
the physical separation of the cells involves disruption of the cell-cell junction,
active retraction and stabilization of new protrusions away from the site of
contact. Since protrusions are stabilized by integrin mediated adhesions, focal
adhesions may be spatially regulated to enable persistent migration. Migration of
cells away from the site of contact may involve a simple disruption of adhesions
or maturation of adhesions followed by dissolution. The nature of adhesions
depends on cell-type and substrate; more work is needed to understand the role
played by adhesions in CIL.
Physiological relevance of contact inhibition of locomotion
Recently CIL, especially homotypic, has been extensively studied in
different systems in vitro as well as in vivo. CIL has been implicated in many
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Figure 5. Co-ordination of directed collective migration through chemoattraction
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physiological phenomena: collective migration, tissue patterning, cell dispersion
and maintenance of tissue boundaries40,51. CIL may regulate dispersion of CajalRetzius cells and macrophages during embryogenesis58. However, the exact
positioning of these cells is not random, and perhaps involves an intricate
balance of homo and heterotypic CIL, as well as other cues present in-vivo.
Heterotypic CIL may be involved in maintenance of tissue borders. This is
particularly relevant in cancer metastasis, since loss of CIL may enable
malignant cells to effectively migrate into tissues. Although loss of CIL has been
proposed to promote invasiveness of cancer cells in vitro, whether the same
happens in vivo remains to be further examined. A shift from E-Cadherin to NCadherin mediated cell-cell contacts correlates with both induction of CIL and
EMT51, although any direct connections between the two phenomena remain to
be examined. Macrophages show an interesting behavior, wherein they appear
to undergo homotypic56, but not heterotypic CIL51. This might be explained by
their role in looking for sites of infection or wounds where homotypic CIL enables
greater spread, and lack of heterotypic CIL enables tissue penetration to
effectively migrate to the site of injury. However, how the macrophages may
overcome homotypic CIL to aggregate at sites of injury is not known. Unlike cell
dispersion, the role of CIL in collective migration, although perhaps counterintuitive, is particularly fascinating (Figure 5). Heterotypic CIL may enable greater
directional persistence of a collectively migrating group of cells by restricting
spread. In addition, homotypic CIL in the presence of co-attraction between
migrating cells may enable efficient protrusion formation and maintenance only in
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cell-free regions (Figure 5). A combination of homotypic and heterotypic CIL
between placode cells and neural crest cells has been demonstrated to be critical
for a ‘chase and run’ behavior that may be critical during embryogenesis. Such
behavior might explain how cells can efficiently respond to relatively low
concentrations of chemoattractants to migrate to their destination. The molecular
mechanisms that lead to collective migration versus cell dispersal stemming from
a seemingly similar phenomenon are not well understood.
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Semaphorin and Plexin signaling
Membrane bound repulsive ligand receptor pairs are of particular interest
in CIL. Ephrins and Eph receptors, and semaphorins and plexins are arguably
the most well studied families of repulsive guidance factors. My work is primarily
focused on Semaphorin 4D and its receptor Plexin-B1, and this section will
provide a brief introduction to semaphorin and plexin signaling.
Functional domains of semaphorins and plexins
Semaphorins are a group of membrane associated or secreted
glycoproteins, which have been categorized into eight groups. Semaphorins
expressed by invertebrates are categorized in groups 1 and 2, and the last group
is reserved for semaphorins expressed in viruses. In vertebrates, semaphorins
have been classified into groups 3 to 7, of which group 3 are secreted and the
rest are membrane associated. Group 4 semaphorins may have an intracellular
PDZ domain, which may be involved in reverse signaling through plexins (Figure
6). All semaphorins have a conserved extracellular ‘Sema’ domain, which shows
structural similarities to β-propeller repeats in α-integrins. Sema domains are
found in the extracellular regions of semaphorins, plexins, and receptor tyrosine
kinases Met and Ron. Plexins are a group of transmembrane proteins and are
the major receptors for semaphorins. Based on sequence homology plexins have
been classified into four groups: A-D. All plexins share a largely homologous
structure (Figure 6): an extracellular sema domain with which they form
heterodimers with semaphorins, a single transmembrane helix, a juxtamembrane
region followed by a RasGAP homology region and a RhoGTPase binding
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domain (RBD). The RasGAP domain is unique in that the domain is divided into
two segments, referred to as C1 and C2, with each segment containing one of
the catalytic arginine residues critical for RasGAP action. C1 and C2 are
connected by an unrelated RBD that associates with GTP-loaded Rho GTPases.
Although the linear sequence C1 and C2 are separated by about 200 amino
acids, structural studies do not reflect any such separation, with C1 and C2
segments cohesively forming a RasGAP domain and the RBD shifted away. The
juxtamembrane region folds into a helix-loop-helix conformation and aligns
between the RasGAP domain and the RBD. Additionally, B family plexins have a
C-terminal PDZ binding domain (PBD) with which they can recruit and activate
PDZ-domain containing RhoGEFs: PDZ-RhoGEF and Leukemia associated
RhoGEF (LARG). Plexin-D1 also has a C-terminal PBD, and has been recently
reported to recruit and activate GIPC1 (GAIP interacting protein, C-terminus 1)
through interaction with its PDZ domain. GTPase binding to plexin-RBD is critical
for the RasGAP activity of plexins. For this reason, plexins are thought to function
as AND gates, integrating extracellular as well as intracellular signals. All
semaphorins, except group 3, directly associate with plexins through their sema
domains. Group 3 semaphorins require neuropilins as a co-receptor for
association with plexins. Neuropilins are single pass transmembrane proteins
with a size of ~900 amino acids. They have very short intracellular regions, and
are generally thought to function primarily as a co-receptor for plexins and
receptors for vascular endothelial growth factors (VEGFR). Whether they directly
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mediate any signaling pathways independent of semaphorins, plexins or
VEGFRs is not well known60–62.
All plexins have a RasGAP domain through which they may inhibit Ras
GTPases. In particular, A and B family plexins have been reported to inhibit RRas, M-Ras and Rap1 GTPases through its RasGAP domain. Although R-Ras
was the first Ras GTPase reported to be regulated by plexin RasGAP domain,
there is some controversy about whether it is indeed directly inhibited by
plexins63–65. Rho GTPase binding to plexin-RBD regulates its RasGAP activity.
As mentioned earlier, B-family plexins recruit PRG and LARG through their Cterminal PBD leading to activation of RhoA66–68. Although the interaction between
Plexin PBD with the PDZ domain of the RhoGEFs is thought to be constitutive68,
GTPase binding to plexin-RBD has been reported to promote RhoA activation69.
The molecular mechanism of GTPase regulation of plexin signaling is not well
understood. This is particularly interesting since structural studies have reported
minimal conformational changes upon Rac1 binding to Plexin-A1 or Plexin-B1
RBD70. Recently, Rac1 and Rnd1 have been reported to bind to a second region
of Plexin-B1 that is proximal to the site of Ras binding. This additional interaction
between Rac1 or Rnd1 with plexins has been proposed to promote a trimeric
conformation of Plexin-Ras complex71.
Group 4 semaphorins have a short intracellular region (~ 20 amino acids)
and have a putative PBD in their C-terminus, which raises the possibility of a
reverse signaling pathway with Plexins acting as the ligand. In immune cells,
Sema4D was reported to associate with a tyrosine phosphatase CD4572.
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Sema4C and Sema4F interact with PSD-95 in neurons73,74. Whether these
associations are dependent on plexin remains to be investigated. Recently,
Plexin-B1 has been reported to act as a ligand for Sema4A, promoting interaction
between Sema4A intracellular domain and Scrib through a PBD-PDZ
interaction75. This association was proposed to competitively inhibit the formation
of β-Pix-Scrib complex, leading to inhibition of Rac1 activity. This in turn has
been proposed to be critical for promotion of cell migration by Plexin-B1,
although how inhibition of Rac1 could lead to migration was not explained.
Family 6 semaphorins have the largest intracellular domain of all
semaphorins, and some of these have proline rich sequences, which may act as
docking sites for SH3 domains. Sema6D intracellular domain forms a molecular
complex with ABL tyrosine kinase through its SH3 domain, and this interaction is
promoted by Plexin-A176. Src kinase may similarly bind with Sema6B77. In
addition to plexins, semaphorins may also have other lower affinity receptors. For
example, Sema4A and Sema4D bind with receptors TIM2 and CD75 in immune
cells78. Whether these receptors may induce reverse signaling through
semaphorins remain to be investigated. Also, the sema domains of semaphorins
and plexins share certain structural homology with extracellular domains of αintegrins, and might associate with β-integrins to activate FAK or other
associated kinases60. However, the exact nature of such association and
downstream signaling needs further investigation.
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Tyrosine kinase activation by plexin signaling
Semaphorins can activate tyrosine kinases through plexins, and may act
as a non-canonical activator for these kinases79. Specific plexins may associate
with different kinases, resulting in differential regulation of downstream signaling,
and cellular response. These associations are dependent on the types of cells,
with the same plexin associating with different kinases in different cells. In
dendritic cells and pre-osteoclasts, Plexin-A1 has been reported to activate
intracellular tyrosine kinase SYK through a complex formation with TREM2 and
DAP1280. In neurons and COS-7 fibroblast-like cells, A-family plexins associate
with Fes and Fyn kinases leading to growth cone or cell collapse81. In the cardiac
system, depending on the cell type, Plexin-A1 may associate with either
VEGFR2 or with OTK to promote or inhibit migratory behavior82. As mentioned
earlier, neuropilins associate with VEGFR, and may regulate complex formation
with Plexin-As83,84. In addition, neuropilins have been implicated in semaphorin
dependent recruitment of FES and FAK kinases85. Sema4D has been reported to
activate ErbB2 or Met through co-clustering with Plexin-B1 through their
extracellular domains in different cells. Activation of either Met or ErbB2 can
phosphorylate unique tyrosine residues on Plexin-B1 intracellular domain, and
also have opposite effects on RhoA activation. This differential signaling leads to
opposite outcomes in cell behavior, with ErbB2 activation associated with
increased motility and Met activation leading to decreased motility86–88.
Conversely, Sema5A induced association of Plexin-B3 with Met has been
reported to promote both cell collapse as well as increased motility89. Sema4D-
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Plexin-B1 signaling has also been reported to activate Src and Pyk2 kinases,
although the molecular pathways connecting these molecules are not currently
well understood90.
Plexin signaling in physiology and pathology
Although semaphorins and plexins were first identified as a family of
repulsive guidance molecules, they are now recognized to play different roles in
different physiological systems; and dysregulation of their signaling is associated
with many pathological states91. Indeed, semaphorins have been reported to act
as both attractive and repulsive cues. For example, Sema3A may induce
collapse of growth cones as well as promote neurite outgrowth92,93. Inhibition of
Sema3A appears to support neural regeneration in instances of corneal
transplant and spinal injuries94,95. Plexins were initially studied in the context of
neuronal guidance. Consistent with their role as repulsive guidance cues,
semaphorins often define regions of exclusion for corresponding plexin
expressing neurons in the brain. Sema4D, Sema7A, Plexin-A1 or Plexin-B1
knock-out mice show reduced susceptibility to development of experimental
autoimmune encephalitis, an experimental model for multiple sclerosis91. In
cultured neurons, Sema4D-Plexin-B1 signaling has been proposed to regulate
dendritic spine density and maturation through RhoA-ROCK signaling96.
Sema3E-Plexin-D1 signaling has been demonstrated to negatively regulate
synapse formation in vivo97.
Plexins play diverse roles in angiogenesis. A-family plexins have been
reported to promote angiogenesis by promoting motility of endothelial cells.
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Surprisingly, this enables both fusions of smaller vessels to form large ones, as
well as division of vessels to form smaller ones that are more spread out to cover
a larger surface area60. Plexin association with VEGFR has been proposed to
promote angiogenesis. Conversely, Plexin-D1 acts as a negative regulator for
angiogenesis, with Sema3E marking regions of exclusion for vasculature98,99.
Sema4A and Sema4D were the first semaphorins identified in immune cells. In
addition to plexins, these semaphorins may utilize Tim2 and CD72 to modulate
immune cell behavior. The major impact of plexin signaling on immune cells may
be mediated by the RasGAP activity on Ras molecules and subsequent
modulation of integrin engagement60,91. Sema4D has been reported to inhibit
migration of monocytes and dendritic cells through Plexin-B1100. Viral
semaphorins show the greatest homology with Sema7A, which is expressed by
immune cells60. Sema7A knock-out mice show resistence to West Nile virus
infection101,102. Vaccinia virus semaphorin (A39R) activates Plexin-C1 signaling,
and has been demonstrated to inhibit migration of monocytes and dendritic cells
towards virus-infected cells, and also inhibit phagocytosis103,104. HIV-1 infection
increases Sema4D expression in dendritic cells, which may promote further
infection105.
In particular due to association with tyrosine kinases and Ras signaling,
plexins have been studied in the context of cancer biology. Plexin-A1 has been
implicated in promoting malignancy in lung cancers106. Plexin-A1 and Plexin-A4
have also been implicated in promotion of tumor growth through its promotion of
angiogenesis91,107–109. Sema4D produced by tumor cells has been reported to

33

attract Plexin-B1 expressing endothelial cells into the tumor microenvironment
and promote angiogenesis, leading to increased tumor growth110,111. However,
the exact mechanism by which Sema4D may act as an attractant is remains
unexplained. Knock-out of Plexin-B1 reduces instances of metastases in ErbB2positive breast cancer in a mice model112. Antibody mediated inhibition of PlexinB2 also reduced tumor growth in a mouse model113. Similarly, knockdown of
Sema3E, or its receptor Plexin-D1 in cancer cells has been reported to reduce
metastasis in a mouse xenograft model114–116. Semaphorins and plexins are now
increasingly being investigated for their roles in skeletal biology117. Sema3A
knock-out mice show an osteopenic phenotype118, whereas Plexin-A1 knock-out
mice have increased bone mass80. Sema4D, Plexin-B1 or Plexin-B1 null mice
have an osteopetrotic phenotype15,119. Soluble Sem4D treatment has been
shown to inhibit osteoblast differentiation in vitro, and may also regulate
osteoclast function. Anti-Plexin-B1 antibodies are being investigated for
therapeutic use in osteoporosis120. As discussed earlier, spatial regulation of cell
migration is particularly relevant in the context of bone remodeling. Although
there is a good deal of information available about semaphorin and plexin
signaling pathways through biochemical assays, little is known about the spatial
regulation of plexin signaling, which is particularly significant in its role as a
repulsive guidance molecule. My work focuses on spatial regulation of Plexin-B1
signaling in osteoblasts, and its impact on directional migration. It is discussed in
details in Chapter II.
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Spatial control of signaling pathways
Conventional approaches of studying the impact of a ligand on cell motility
usually involve ligand perfusion in culture and observing changes in cell
morphology or motility. Boyden chamber assays have been utilized to
characterize the response of cells to chemo-attractants and repellents. However,
such assays often involve concentration gradients far beyond physiologically
relevant levels, and do provide little information regarding the spatial and
temporal coordination of cell polarizing events that enable directional response to
these stimuli. Repulsive interactions between cells have in particular been
predominantly studied by utilizing bath application of soluble ligands with an
expectation of a cell or protrusion collapse as the end point. More recently,
microfluidic devices have been utilized to get greater control of concentration
gradients45; but such control often comes with the caveat of movement restricted
in a single dimension. CIL has been investigated by investigating collisions
between randomly migrating cells, and utilizing ligand immobilized on solid
beads. Since contact between cells may engage many signaling pathways, it is
difficult to establish causality utilizing cell-cell interaction, especially in the
absence of stark phenotypes. Although ligand-coated beads may alleviate such
concerns, collisions in a culture sparse enough to observe single cell behavior is
a low probability event, which makes investigating spatial regulation of signaling
events particularly difficult. Recently, optogenetic approaches have been
successfully used to achieve spatial and temporal resolution in initiating signaling
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pathways in vitro and in vivo. Some of these approaches are discussed in this
section.
Optogenetic toolkits for cell biology
Optogenetics is generally defined as genetically encoded tools expressed
in living cells (or animals) that enable the use of light to drive signaling pathways.
In other words, optogenetic tools are light dependent actuators of molecular
pathways.

The

prototypical

optogenetic

tool

was

based

on

plant

channelrhodopsin2 that was utilized in cultured mammalian neurons to generate
light mediated membrane currents121,122. Since then, many more optogenetic tools
have been developed for use in the context of neuroscience. Genetic encoding
enables expression of the light sensitive proteins in specific neurons. Since only
these particular neurons are now sensitive to illumination, light can now be used
as a trigger to map out the neural network and effects of specific neuronal circuits
in cellular response and animal behavior. Huge strides have indeed been made in
our understanding of relationship between animal behavior and specific neural
circuits. In addition to the basic research and understanding, optogenetic
approaches are being investigated to design light based therapies. Light
dependent stimulation enables better temporal control than conventional
approaches, and also allows spatial restriction of signaling pathways to subcellular
regions. Furthermore, many optogenetic tools are reversible in nature, enabling
investigation of cyclic activation of pathways. These particular properties make
optogenetic approaches highly desirable in understanding spatiotemporal
regulation of signaling pathways in cells. Optogenetic tools to activate specific
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signaling cascades are usually developed using chimera proteins with light
sensitive modules that undergo a desirable change upon illumination and the
proteins of interest whose signaling should be activated upon illumination. In this
section, I will briefly discuss some of the optogenetic modules that have been
developed and utilized in the recent years to understand spatial and temporal
regulation of signaling pathways in the field of cell biology.
LOV domain: The Light-Oxygen-Voltage domains are blue-light sensitive
(~440-470 nm) protein domains that are found in plant, bacterial, algal and fungal
species. LOV domains contain a Period-ARRNT-singleminded (PAS) domain core
with a flavin cofactor. Light activation of the flavin cofactor leads to unfolding of the
C-terminal J-α helix and undocking from the PAS core123,124. This conformational
change in the LOV domain was exploited to successfully design many optogenetic
modules. Photoactivatable Rac1 (PA-Rac1) based on the LOV2 domain of Avena
sativa phototropin1 (AsLOV2) was the first genetically encoded tool for activating
a small GTPase using light125. PA-Rac1 adopts an autoinhibited conformation in
dark, wherein the LOV-domain would sterically block the effector-binding domain
of a constitutively active mutant of Rac1 (Figure 7a). Upon blue light activation, the
J-α helix unwinds to expose the effector-binding domain, which is now available to
initiate downstream signaling cascades. Localized activation of PA-Rac1 induced
membrane ruffling and directional migration in cells, in vitro and in vivo125,126. The
AsLOV2 domain has been utilized to develop an optogenetic module (iLID) that
undergoes hetero-
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Figure 7. LOV domain based optogenetic modules. (a) Photoactivatable Rac1, and
other small GTPases, (b) iLID dimerization tool and (c) LOVTRAP
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dimerization upon illumination127. iLID dimerization module utilizes high affinity
protein hetero-dimerization pairs: seven amino acid residues from bacterial SsrA
protein that shows structural homology with the J-α helix was fused at the Cterminus of the helix (Figure 7b). In the dark, the J-α helix occludes the SsrA
residues from binding with another bacterial protein SspB, and this inhibition was
relieved upon light dependent unwinding of the J-α helix. In addition, point
mutations were introduced in the AsLOV2 and SspB domains to modulate the dark
and light affinity of the iLID components. The iLID dimerization module has been
utilized to efficiently translocate proteins from one cellular compartment to another.
Conversely, another AsLOV2 domain based optogenetic hetero-dimerization
module (LOVTRAP) was recently developed that exists as a dimer in dark, and
undergoes dissociation in light128 (Figure 7c). LOVTRAP module may be utilized
to sequester exogenously expressed proteins to specific cellular compartments in
dark, and release them into the cytosol using light dependent dissociation.
Vivid and Magnets:

Vivid (VVD) is a fungal LOV domain from the

filamentous fungi Neurospora crassa. VVD utilizes a flavin cofactor for
photoactivation, and undergoes homodimerization upon blue light activation
(Figure 8a). Of the many optogenetic dimerization (or oligomerization) modules
currently available, VVD is the smallest in size. However, because it forms a weak
homodimer, it is difficult to use VVD for efficient and specific translocation.
Furthermore, VVD has very slow dark recovery rates129. Recently, targeted
mutations were applied to the dimerization interface of VVD to increase the
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Figure 8. Vivid (VVD) based optogenetic dimerization modules. (a) VVD homodimerization and (b) Magnets undergoing hetero-dimerization and not homodimerization.
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number of either positively or negatively charged residues130. This produced two
distinct VVD variants that would preferably heterodimerize through electrostatic
interactions. In addition, other mutations were applied to the VVD molecule to
significantly improve its dark recovery kinetics. This new VVD based
heterodimerization module is called Magnets (Figure 8b). AsLOV2, PhyB and Cry2
based dimerization modules (discussed next) have a disadvantage in that only one
of the molecules is photoresponsive, and so it may be difficult to maintain a very
tight spatial control due to diffusion of photoactivated dimers. Magnets have the
unique

property

that both

the

molecules

undergoing

dimerization

are

photosensitive, which may enable better spatial control compared to other
optogenetic modules. Unlike other dimerization modules, Magnets interact through
electrostatic interactions, and that might limit their usage in case of target proteins
with highly charged surfaces.
PhyB-Pif: Phytochrome B (PhyB) is another plant photoreceptor that is
activated by red light (650 nm) and inactivated by far red light (~750 nm). For
activation, PhyB requires a phycocyanoblin (PCB) cofactor, which is synthesized
by photosynthetic organisms131. When exogenously expressed in mammalian
cells, PCB must be externally supplied such that PhyB may auto-catalytically ligate
with PCB and become photosensitive. Upon red light activation, PCB bound PhyB
can bind to a transcription factor called Phytochrome interacting factor 6 (PIF6)
(Figure 9). This heterodimer is stable for hours in dark, and can be induced to
rapidly dissociate by illumination with far red light (~750 nm). Although the
inducible reversibility of the PhyB-PIF6 toolkit is
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Figure 9. Phytochrome-B based optogenetic dimerization module. PhyB,
Phytochrome-B. PCB, Phycocyanobilin. Pif-6, Phytochrome interacting factor 6
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particularly attractive, the need to add an exogenous co-factor to ‘complete’ the
system makes it cumbersome, especially since the purity of the PCB can have a
big impact on the efficiency of light response. On the other hand, this may be used
to one’s advantage, since unlike other optogenetic modules, there is no need to
exclude light from experimental samples until PCB is made available. Recently,
biosynthetic enzymes have been designed that may be exogenously expressed in
mammalian cells to produce PCB.
Cyrptochrome-2: Cryptochrome 2 (Cry2) from Arabidopsis thaliana is
another plant photoreceptor that is activated by blue light (~400-490 nm). Cry2
utilizes endogenously expressed flavin molecule for activation. Cry2 responds to
blue light by undergoing homo-oligomerization to form protein clusters (Figure 9a)
and hetero-dimerization with a transcription factor Cryptochrome interacting basic
helix-loop-helix protein (CIB1) (Figure 9b). These unique responses make Cry2
particularly attractive in developing light dependent hetero-dimerization and/or
clustering modules132–134. Similar to iLID and the PhyB-PIF system, the heterodimerization property of Cry2-CIB1 enables recruitment of a protein of interest to
a specific compartment. Cry2 has a relatively slow off-rate in dark (minutes)
compared to iLID (seconds). Although this restricts the usage of Cry2 module for
rapid switching between on and off states, it also allows for maintenance of
localized photoactivation with lesser degree of illumination, and enables
investigating changes in other signaling molecules. A point mutation that
significantly enhances the oligomerization property of Cry-2 (Cry2-olig) has been
utilized to activate robust clustering upon photoactivation135.
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Figure 10. Cryptochrome 2 based optogenetic modules. (a) Homo-oligomerization
of Cry2 and (b) heterodimerization of Cry2 with CIB1. Cry2, cryptochrome 2. CIB1,
cryptochrome interacting basic helix-loop-helix protein.

44

All of these optogenetic modules have been utilized to develop tools to
photoactivate different signaling cascades in living cells and animals, ranging from
transcriptional regulation to directional migratory response. I have used the Cry2CIB1 module for optogenetic activation of Plexin-B1 signaling in cells, and
discussed the details of the tool design in Chapter II.
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CHAPTER II
Optogenetic activation of Plexin-B1 reveals contact-repulsion between
osteoclasts and osteoblasts

Abhijit Deb Roy, Taofei Yin, Shilpa Choudhary, Vladimir Rodionov, Carol
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Abstract
During bone remodeling, osteoclasts induce chemotaxis of osteoblasts and yet
maintain spatial segregation. We show that osteoclasts express the repulsive
guidance factor Semaphorin 4D and induce contact inhibition of locomotion (CIL)
in osteoblasts through its receptor Plexin-B1. To examine causality and elucidate
how localized Plexin-B1 stimulation may spatiotemporally coordinate its
downstream targets in guiding cell migration, we develop an optogenetic tool for
Plexin-B1 designated optoPlexin. Precise optoPlexin activation at the leading
edge of migrating osteoblasts readily induces local retraction and, unexpectedly,
distal protrusions to steer cells away. These morphological changes are
accompanied by reorganization of Myosin II, PIP3, adhesion and active Cdc42.
We attribute the resultant repolarization to RhoA/ROCK-mediated redistribution
of β-Pix, which activates Cdc42 and promotes protrusion. Thus, our data
demonstrate a causal role of Plexin-B1 for CIL in osteoblasts and reveals a
previously unknown effect of Semaphorin signaling on spatial distribution of an
activator of cell migration.
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Introduction
In multicellular organisms, migrating cells respond to attractive or repulsive
cues to precisely control speed and directionality and reach their destination with
spatial and temporal accuracy. Contact inhibition of locomotion (CIL) describes the
repulsive effect on a migrating cell upon contact with another cell. CIL has been
implicated in many physiological and pathological phenomena such as embryonic
development, tissue patterning, collective migration and cancer metastasis. While
CIL has long been observed in vitro17,36,136 and recently in vivo47,56,58,59,137, the
precise spatial and temporal dynamics of the underlying signaling remain obscure.
Guidance molecules such as semaphorins have been proposed to mediate
repulsion in vivo44,66,138,139. In vertebrates there are 5 classes of semaphorins,
numbered from 3 to 7, each comprising of several members60. Excluding
Semaphorin 3s, which are secreted, most semaphorins are either transmembrane
or membrane-tethered proteins, suggesting a prerequisite role of cell-cell contact in
their signaling. Semaphorins signal primarily through the Plexin family of singlepass transmembrane receptors60. Semaphorins interact with plexins through their
respective extracellular sema domains61,140. The binding is thought to relieve
autoinhbition of the receptor and mediate clustering of plexin intracellular
domains71,141,142. The intracellular region of plexins contains a RasGAP domain
that inactivates R-Ras63. B family plexins contain a PBZ binding domain (PBD) at
their C-terminus through which they associate with two PDZ-domain containing
RhoGEFs, PDZ-RhoGEF (PRG) and Leukemia-associated RhoGEF (LARG), and
activate RhoA67,68,143.
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During bone remodeling osteoclasts release different factors to mediate
chemotaxis of osteoblasts to the site of resorption144,145,8,9. Semaphorin 4D
(Sema4D) expressed by osteoclasts, has been shown recently to regulate
osteoblast-mediated bone formation15,119. Ablation of Sema4D or Plexin-B1
reduced the spacing between osteoclasts and osteoblasts in vivo15, suggesting
that osteoclasts may also repel osteoblasts, which is contrary to the paradigm of
chemoattraction between the cells. Whether osteoclasts induce repulsion in
osteoblasts has not been directly demonstrated and the molecular pathways that
may mediate such response have not been explored.
In the current study, we demonstrate that osteoclasts repel osteoblasts
upon contact and determine that CIL between these cells is dependent on
Sema4D-Plexin-B1 signaling. To elucidate the spatiotemporal dynamics of PlexinB1 downstream effectors that mediate repulsion, we develop an optogenetic tool
(optoPlexin) to initiate Plexin-B1 signaling at precise times and subcellular
locations. In contrast to a collapse phenotype upon whole cell activation, localized
optoPlexin stimulation induces a coordinated retraction at the site of illumination
and protrusions at distal regions. Similar to CIL with osteoclasts, the repulsion
phenotype induced by precise optoPlexin stimulation does not alter the inherent
motility of the cells. Employing biosensors for Myosin II, PIP3 and Rho GTPases
including RhoA, Cdc42 and Rac1, we define the spatial and temporal regulation of
signaling downstream of Plexin-B1. Finally, we identify a novel mechanism by
which Plexin-B1 coordinates cell repolarization through RhoA-ROCK mediated
redistribution of β-Pix.
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Results
Osteoclasts induce contact inhibition of locomotion in osteoblast.
To examine whether osteoclasts affect osteoblast migration, we isolated
primary bone marrow macrophages (BMMs) and primary calvarial osteoblasts
(POBs) from mice. Upon differentiation in culture, the BMMs formed multinucleated
osteoclasts and were then overlaid with POBs. Similar to earlier reports, we
observed that the osteoclasts pushed the obsteoblasts away upon contact17,18.
There were physical gaps between these two cell types and the osteoblasts lacked
lamellipodial protrusions toward the osteoclasts (Figure 11a, Movie 1). To
investigate how osteoblast migration was altered, we performed a “wound healing”
assay (Figure 12a, b) in which POBs or MC3T3-E1 cells were seeded next to
osteoclasts. On removing the insert, both POBs (Movie 2) and MC3T3-E1 cells
(Movie 3) formed lamellipodial protrusions and migrated towards the osteoclasts.
Upon contact with osteoclasts, these protrusions rapidly collapsed, followed by
formation of new protrusions away from the site of contact and a change in
migration direction (Figure 11b, 12d, Movies 2, 3). In MC3T3-E1 cells, the
protrusions collapsed on average 6 minutes after initiation of contact with
osteoclasts and new distal protrusions formed about a minute after (Figure 13a).
While the migration speed before and after contact remained unaltered (Figure
13b), the contact acceleration index (Cx, see methods for details) showed a clear
reversal of migration direction with respect to the trajectory before contact
(negative values). The Cx approached zero prior to contact indicating directional
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Figure 11. Osteoclasts repel osteoblasts on contact. (a) Phase contrast images
showing separation between osteoclasts and osteoblasts in a co-culture. The inset
(106 μm X 92 μm) is magnified on the right panel to show the gap between the
osteoclast and the osteoblasts and the lack of protrusions in osteoblasts. The arrows
point towards the osteoblasts. (b) Phase contrast images showing contact between
an osteoblast and an osteoclast. The inset is magnified to show changes in cell
morphology and migration between time of contact and 20 and 40 minutes after
contact. White triangle points to the site of cell-cell contact. Scale bar, 50 μm.
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Figure 12. Plexin-B1 mediates CIL between osteoclasts and osteoblastic cells. (a)
Cartoon representation of culture inserts used for co-culture of osteoclasts with
primary osteoblasts or MC3T3-E1 cells. (b) Phase contrast images acquired
immediately and 12 hours after lifting the culture insert showing migration of MC3T3E1 cells towards osteoclasts. Scale bar, 50 μm. (c) Comparison of Plexin-B1 expression
in wild type (WT), Cas9, KO1 and KO2 MC3T3-E1 cells. Tubulin was used as a loading
control. (d), (e) Phase contrast images showing a MC3T3-E1 WT (d) or MC3T3-E1 KO1
(e) cell in contact with an osteoclast (OC). Insets are magnified to show changes in cell
morphology and migration between time of contact and 20, 30 and 40 minutes after
contact. Scale bar, 50 μm. White triangles point to the site of cell-cell contact. (f)
Percentage of WT, Cas9, KO1 and KO2 MC3T3-E1 cells that show collapse of
protrusions within 30 minutes after contact with an osteoclast. n = 209-301. (g)
Separation between MC3T3-E1 cells and osteoclasts 40 minutes after contact. n = 4145. (h) Cartoon describing contact acceleration index (Cx). (i) Cx values for WT cells,
Cas9, KO1 and KO2 MC3T3-E1 cells without (WT only) and after contact with
osteoclasts. n = 20. For g and I means ± s.e.m. are shown. *** p<0.001, * p<0.05, NS,
not significant, Student’s t-test.
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Figure 13. Characterization of CIL between osteoclasts and osteoblasts (a) Delay in
initiation of retraction at the site of contact and initiation of new distal protrusions in WT
MC3T3-E1 cells upon contact with osteoclasts. n=85 cells, mean ± s.e.m. are shown. (b)
Velocities of MC3T3-E1 cells coming in contact with osteoclasts, normalized to the
velocity right before contact at time 0 . n=29 cells, mean ± s.e.m. are shown. *** p<0.001,
* p<0.05, NS, not significant.
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Figure 14. Sema4D/Plexin-B1 expression and knock-out strategy (a) Comparison of
Sema4D mRNA expression in pre-osteoclasts (BMMs treated with M-CSF) and
osteoclasts (BMMs treated with M-CSF and RANKL) from Cd1 and C57BL/6 mice.
Osteoclastogenesis was confirmed by visual inspection of formation of
multinucleated cells on fourth day of RANKL treatment. und, undetectable. (b)
Comparison of Plexin-B1 mRNA expression in MC3T3-E1 cells and primary calvarial
osteoblasts from C57BL/6 mice. mRNA were extracted after 7 and 14 days of
phosphoascorbate mediated differentiation. (c) Comparison of Plexin-B1 expression
in MC3T3-E1 and pimary calvarial osteoblasts from C57BL/6 mice after 7 and 14
days of maintenance in differentiating media. COS-7 cells overexpressing Plexin-B1
were used for positive control. (d) Comparison of Plexin-B1 expression in WT
MC3T3-E1 cells and MC3T3-E1 cells stably expressing shRNA against Luciferase (Luc)
or Plexin-B1 (sh1, sh2 and sh3). (e) Comparison of Plexin-B1 expression in WT
MC3T3-E1 cells and cells transiently transfected with a non-targeting siRNA pool
(Ctrl) or Plexin-B1 siRNA pool (PlxnB1). (f) Cartoon representation of the sgRNA
design strategy for CRISPR-Cas9 mediated Plexin-N1 knock out (see main text). (g)
Comparison of PCR product using primer 1 and 2 on genomic DNA in WT, Cas9, KO1
and KO2 MC3T3-E1 cells to probe for deletion targeted by sgRNA1 and sgRNA2.
For a & b means ± s.e.m. are shown, n=3 wells of cells. *** p<0.001, * p<0.05, NS,
not significant. For c, d and e tubulin was used as a loading control.
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Figure 15. Pre-osteoclasts do not induce CIL in osteoblasts (a) Phase contrast images
showing contact between a MC3T3-E1 cells and a BMM. (b) Percentage of MC3T3-E1
cells that show collapse of protrusions within 30 minutes after contact with a BMM or
an osteoclast. n ≥ 40. ***, p<0.001. (c), (d) Phase contrast images showing contact
between MC3T3-E1 Cas9 (c) or MC3T3-E1 KO2 (d) cell and an osteoclast. The inset is
magnified to show changes in cell morphology and migration between time of contact
and 30 minutes after contact. Scale bar, 50 μm. White triangles point to the site of
cell-cell contact.
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Table 1. List of primers used for CRISPR-Cas9 mediated Plexin-B1 knock-out
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persistence (Figure 12h, i). Thus our data indicates that osteoclasts induce CIL in
obsteoblasts without compromising their intrinsic motility.
Plexin-B1 mediates osteoclast-induced CIL in osteoblasts
Sema4D is expressed by BMMs upon differentiation to osteoclastic lineage
using Receptor activator of nuclear factor κ-B ligand (RANKL). Consistent with
previous reports15,119, Sema4D expression was undetectable in BMMs, but was
markedly increased during RANKL-mediated osteoclastogenesis (Figure 14a). In
support of a role of Sema4D in CIL, BMMs failed to induce collapse of protrusions
or change in direction of migration in MC3T3-E1 cells (Figure 15a, b, Movie 4).
Both POBs and MC3T3-E1 cells expressed Plexin-B1 and no significant changes
were observed in mRNA or protein levels upon differentiation (Figure 12c, 14b, c).
To examine whether CIL between MC3T3-E1 and osteoclasts was mediated by
Plexin-B1, we conducted knock-down experiments with several independent
shRNA lentivirus, siRNA pools as well as CRISPR/Cas9-mediated knock-out
experiments. Despite our best efforts, only modest silencing of protein expression
(Figure 14d, e) was achieved with siRNA and shRNA without compromising cell
motility. In contrast, the CRISPR/Cas9 mediated knockout approach (see Methods
for details) completely eliminated Plexin-B1 expression (Figure 12c). Two PlexinB1 null MC3T3-E1 clones, KO1 and KO2, were used in cell migration assays.
Cas9 expression alone did not affect Plexin-B1 expression (Figure 12c), nor did it
alter osteoclast-mediated contact repulsion of MC3T3-E1 cells (Figure 12f, 15c,
Movie 5). KO1 and KO2 cells failed to show collapse of protrusions upon contact
with osteoclasts and maintained contact with osteoclasts for prolonged periods of
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time (Figure 12e, f, 15d, Movies 6, 7). Furthermore, KO1 and KO2 cells did not
migrate away from the osteoclasts (Figure 12g). Finally, comparison of Cx values
(Figure 12i) indicated that in contrast to WT and Cas9 cells, KO1 and KO2 cells
failed to undergo repulsion after contact. Thus our data demonstrated that PlexinB1 is required for CIL in osteoblastic MC3T3-E1 cells.
Development of an optogenetic tool for the Plexin receptor
To activate Plexin-B1 in osteoblasts, we initially attempted several Sema4D ligand
based approaches. Perfusion of soluble Sema4D-Fc ligand induced RhoA
activation in MC3T3-E1 cells and cell collapse as indicated by loss of protrusions
and decrease in total cell area (Figure 16). Contact between osteoclasts and
osteoblasts may initiate Sema4D-Plexin-B1 signaling specifically at the site of
contact. To understand the role of Plexin-B1 in CIL, we locally pumped Sema4DFc near protrusions of POBs using a microinjection pipette (Figure 17). The cells
responded with a blunted protrusion or retraction locally and 4 out of 5 times
produced a new protrusion(s) in distal regions, which is consistent with CIL. In
contrast, no significant morphological changes were observed with control IgG1
(Figure 17). Because it is difficult to confine soluble ligand in the medium, we used
immobilized Sema4D-Fc on silica beads as localized sources of Sema4D
stimulation. Despite rapidly clustering Plexin-B1 on the plasma membrane (Figure
18, Supplementary Movie 8), the Sema4D-Fc beads failed to induce RhoA
activation, morphological changes or even recruit RhoGEFs (Figure 19, 20, see
Methods for details).
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Figure 16. Sema4D induces RhoA activation and cell collapse in osteoblastic cells. (a)
Ratiometric images showing changes in morphology and RhoA activation in MC3T3-E1
cells expressing DORA-RhoA on treatment with 200 nM Sema4D-Fc or hIgG1. Scale
bar, 10 μm. (b) Changes in cell area of MC3T3-E1 cells treated with 200 nM Sema4D-Fc
or 200 nM hIgG1, normalized to cell area before treatment. n ≥ 11 cells. (c) Changes in
RhoA activity of MC3T3-E1 cells treated with 200 nM Sema4D-Fc or 200 nM hIgG1,
normalized to activities before treatment. n ≥ 11 cells. (d) Temporal changes in RhoA
activity in MC3T3-E1 cells treated with 200 nM Sema4D-Fc. n=17 cells. For b,c and d
means ± s.e.m. are shown. *** p<0.001, * p<0.05, NS, not significant.
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Figure 17. Localized perfusion of Sema4D induces CIL-like repolarization in primary
osteoblasts. Representative DIC images showing changes in morphology in murine
calvarial osteoblasts from C57BL/6 mice upon localized Sema4D-Fc or hIgG1(control)
perfusion. Calvarial osteoblasts were differentiated for 7 days before imaging. 1 μM
Sema4D-Fc or hIgG1 was perfused at protrusions using positive pressure through a
micropipette. Local perfusion of Sema4D-Fc induced local retractions and distal
protrusions in osteoblasts (4 out of 5). No morphological changes observed in
response to local perfusion of hIgG1 (3 out of 3). Scale bar, 10 μm. Asterisk, induced
retraction. Arrowhead, induced protrusion.
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Figure 18. Sema4D immobilized on silica beads clusters Plexin-B1. DIC and wide-field
fluorescent images showing changes in Plexin-B1-mCherry distribution in COS-7 cells
before and 10 minutes after contact with Sema4D-Fc (a) or hIgG1 (b) immobilized on
silica beads. Scale bar, 10 μm. The insets are magnified to show changes in
distributionPlexin-B1-mCherry around Sema4D-Fc beads or hIgG1 beads. Scale bar, 5
μm. (c) mCherry intensity in 5 μm circle around beads and beads free cell body after
10 minutes of contact with beads, normalized to intensity in beads free regions. n ≥
70 regions, mean ± s.e.m. are shown. (d) Percentage of beads that show clustering of
mCherry around it. n ≥ 230 beads. (e) Temporal changes in Plexin-B1-mCherry
clustering around Sema4D-Fc beads. n= 5 cells, mean ± s.e.m. are shown. ***
p<0.001, * p<0.05, NS, not significant.
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To mimic local initiation of Sema4D signaling, we used an optogenetic approach
to activate the plexin receptor. We took advantage of the observations that both
the RasGAP activity of Plexin-B1 and its activation of RhoA require its
localization to the plasma membrane and that semaphorin-dependent clustering
of plexin promotes its activation71,141,142. A recently characterized optogenetic
module Cryptochrome-2 (Cry2) was used with a farnesylated Cryptochrome
interacting basic helix-loop-helix 1 (CIB1-CAAX), to induce a plasma membrane
translocation of cytosolic proteins in response to blue light132. Furthermore, Cry2
oligomerizes in light, and could be used to induce protein clustering133. We
constructed a chimera protein containing Cry2 at the N-terminus, followed by a
fluorescent protein (mCherry or mVenus), and finally the intracellular domain
Plexin-B1 at the C-terminus (Figure 21), which preserved its interaction with PRG
and LARG. Full-length Cry2 was used to minimize background activity in the
dark37. Because the engineered Plexin-B1 was designed to be activated by light
instead of Sema4D ligand, we named it optoPlexin (Figure 21, 22a).
To examine whether optoPlexin undergoes a plasma membrane
translocation in response to light stimulation, we co-expressed mCherry-optoPlexin
and CIB1-CAAX in COS-7 cells and used total internal reflection fluorescence
(TIRF) microscopy to gauge the membrane association of optoPlexin. Upon blue
light (440 nm LED) illumination over the entire cell, mCherry intensity increased
immediately after the first pulse of illumination. The rate of increase appeared to be
at a similar time scale as Cry2 alone and, with our illumination protocol of 10
second intervals, reached half maximal intensity within three pulses, indicating a
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rapid recruitment of optoPlexin to the plasma membrane (Figure 22b top panel, 23,
Supplementary Movie 9 left panel). The average increase in the intensity of
optoPlexin and optoPlexin mutants (Figure 21) were close to two-fold,
indistinguishable from that of Cry2 alone (Figure 22c, 24). Additionally, optoPlexin
formed clearly visible fluorescent aggregates, indicating clustering of optoPlexin
(Figure 22d, Figure 25). A flavin adenine dinucleotide (FAD)-deficient mutant of
Cry2 (D387A) that does not absorb blue light146 failed to recruit optoPlexin
(Supplementary Movie 9 right panel). Since a lack of FAD may potentially
compromise the folding of Cry2 or optoPlexin, we also examined an alternate
mutation of Cry2 (D393A) which preserves the FAD-binding pocket but eliminates
the proton donor (Asp393) for FAD and blocks signal transduction of crytochrome in
plants147,148. No membrane recruitment took place for either Cry2 alone or
optoPlexin carrying the D393A mutation (Figure 22c), demonstrating that the
observed effects were specific to the photoreaction of Cry2. More effective
recruitment, an average induction of 4-fold within the region of illumination (Figure
22b,c), was observed when illumination was limited to a 5 μc-diameter circle
within the cells. These data demonstrated that optoPlexin can be efficiently
recruited to the plasma membrane and cluster in response to light stimulation.
Robust activation of RhoA by optoPlexin on light stimulation
Upon Sema4D stimulation, Plexin-B1 interacts with and activates PRG or LARG
through its C-terminal PBD and consequently activates RhoA66,68,143. To test
whether optoPlexin could interact with PRG and LARG, we examined the
membrane recruitment of these two RhoGEFs by co-expressing mVenus-PRG or
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mVenus-LARG in COS-7 cells. Upon whole-cell illumination, we observed a rapid,
concurrent co-recruitment of PRG (Figure 26a, b, Supplementary Movie 10) or
LARG (Figure 26b) with optoPlexin to the plasma membrane. The kinetics of PRG
recruitment and dissociation from the membrane closely followed that of
optoPlexin. Co-recruitment of PRG was reversible upon pausing blue light
illumination, and repeatable with a second round of illumination (Supplementary
Figure 23). An increase in fluorescence of 26% ± 3% and 60% ± 6% (mean ±
s.e.m.) relative to that of optoPlexin were observed for PRG and LARG
respectively (Figure 26b), suggesting an efficient recruitment of RhoGEFs to the
plasma membrane by optoPlexin. Since optoPlexin may also interact with
endogenous PRG and LARG, the extent to which signals were transmitted from
optoPlexin to these two RhoGEFs were most likely underestimated. When Cry2
alone was used as a control, no membrane recruitment of these two RhoGEFs
was detected (Figure 26b). Illumination of cells expressing a PBD-truncated mutant
(delPBD) (Figure 21) showed no increase of PRG levels on the plasma membrane
(Figure 26c) indicating that PBD-PDZ interaction mediates RhoGEF association
with optoPlexin. The interaction between optoPlexin and PRG did not appear to be
constitutive. Upon illumination PRG formed quantifiable aggregates (see Methods
for details) along with optoPlexin in addition to membrane recruitment (Figure 25).
When we omitted the CIB-CAAX from optoPlexin, the clustering of optoPlexin
remained visible using TIRF imaging but we did not detect any clustering of PRG
(Figure 26d, e), suggesting that membrane translocation is critical for activation of
optoPlexin.
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Figure 21. Functional domains of optoPlexin and its variants. A diagram depicting
the domain organization of Plexin-B1, optoPlexin and its mutants. Plexincyto,
intracellular domain of Plexin-B1. WT, wild type. Sema, Sema domain. TM,
transmembrane region. JM, juxtamembrane region. C1 and C2, N and C-terminal
halves of Plexin-B1 RasGAP domain. RBD, Rho GTPase binding domain that binds to
Rac1 and Rnd1. PBD, PBZ binding domain. FP, fluorescent protein. PRR, proline rich
region. aa, amino acids.
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Figure 22. Design and characterization of optoPlexin. (a) Cartoon representation of
the optoPlexin design (see main text). FP, fluorescent protein, Plexincyto, cytosolic
domain of Plexin-B1. (b) TIRF images showing the plasma membrane recruitment of
mCherry-optoPlexin in COS-7 cells after one minute of whole cell or local illumination
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circle, region of illumination. (c) Quantification of the recruitment levels of Cry2,
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illumination in COS-7 cells. n = 12-20, means ± s.e.m. (d) TIRF images showing the
clustering of mCherry-optoPlexin after one minute of whole cell illumination in COS-7
cells. Scale bar, 10 μm. NS, not significant, Student’s t-test.
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To directly test whether RhoA was activated upon optoPlexin stimulation,
we employed the Dora-RhoA biosensor described previously42,43. Due to
overlapping wavelengths, the excitation light for Dora-RhoA FRET sensor was
sufficient to induce rapid membrane recruitment of mCherry-optoPlexin in COS-7
cells (Figure 25, 26f upper panel). Although this prevented us from accurately
capturing the level of RhoA activation prior to illumination, a consistent increase of
RhoA activation was readily detectable (Figure 3f lower panel, 27), with an average
of 70% induction of RhoA activation within the first three acquisitions (Figure 26g,
27b). Spatial pattern of RhoA activation did not accurately match with optoPlexin
recruitment levels, potentially due to spatial regulation of RhoA activation through
other factors. Consistent with being further downstream of Plexin-B1, the activation
of Dora-RhoA exhbited a delay (~20s) in comparison with the membrane
recruitment of optoPlexin (Figure 27b). Importantly, the effects were specific
because no RhoA activation was detected when Cry2 alone or optoPlexin-delPBD
was used, or when CIB-CAAX was omitted (Figure 26g). Sema4D dependent
ErbB2 association with Plexin-B1 mediates downstream RhoA activation in
osteoblasts15,86,149. However, neither inhibiting ErbB2 with Erlotinib150 nor
mutations designed to abrogate ErbB2 regulation of Plexin-B1149 (optoPlexin-YF)
(Figure 21) had any negative impact on PRG co-recruitment (Fig 28a, b); in fact
we observed increased PRG recruitment in both cases (Figure 28c). OptoPlexinYF induced RhoA activation at levels comparable to optoPlexin-WT(Figure 26g).
Based on these results, we concluded that optoPlexin exhibits minimal background
activity in the dark and activates RhoA robustly upon illumination.
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Induction of CIL upon local activation of optoPlexin
To precisely control where Plexin-B1 is activated, we expressed optoPlexin
and CIB-CAAX in MC3T3-E1 cells, and illuminated a 5-μm circular region in
protrusions to mimic contact with Sema4D-expressing osteoclasts. As optoPlexin
continued to accumulate, the illuminated protrusion collapsed and started to retract
(Figure 29a, indicated with an asterisk, Supplementary Movie 11). The effects of
optoPlexin were better illustrated in kymograph analyses where the accumulation
of optoPlexin and the sharp transition of the cell border became apparent (Figure
29c). Despite similar enrichment in the illuminated protrusions, optoPlexin-delPBD
failed to induce retraction (Figure 29b, c, Supplementary Movie 13), suggesting
RhoA activation is required for optoPlexin-induced retraction. Among the
optoPlexin-expressing cells, the average delay from the start of illumination to
initiation of retraction was 2.5±0.5 minutes (mean ± s.e.m., Figure 29d).
Interestingly, in addition to retraction, we observed either formation of a new
protrusion(s) (Figure 29a, indicated with an arrowhead) or enhancement of an
existing protrusion(s) distal to the site of illumination. They appeared immediately
after the initiation of retractions, with an average time delay of 75 seconds (Figure
29d, e), suggesting that they may be mechanistically coupled. Even though
optoPlexin induced retraction locally (Figure 30a), the overall cell area remains
unchanged (Figure 30b).
To quantify the effects of optoPlexin on motility, we superimposed images of
the cell boundary before and 7.5 minutes after illumination, and determined the
relative orientations of the illumination site, retraction and protrusion with respect to
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the centroid of the cell immediately prior to illumination (Figure 30d). Retractions
were closely aligned with the orientation of the illumination site (Figure 30e, g),
whereas new protrusions were randomly distributed (Figure 30f, g). Since the
centroid is dictated by the original cell shape, thereby influencing the relative
orientations of protrusion and retraction, we also measured the linear distance
between protrusive or retracting regions and the site of illumination (Figure 30d).
Retractions took place within 10 microns of the site of illumination, as compared to
protrusions, which were significantly farther from the site of illumination (Figure
30h). Persistent illumination in protrusions effectively repolarized the cells and and
significantly altered their direction so that the cells migrated away from the region
of illumination (Supplementary Figure 31a, Supplementary Movie 12). In some
cases we had to change the region of illumination to new protrusions to effectively
guide the cells. Tracing the displacements of the centroid and the nucleus of one
such cell showed a gradual change in centroid direction preceding a sharp change
in the direction of nuclear migration (Figure 31b, c). Consistent with our
observations with osteoclast co-culture (Figure 13b), we did not observe significant
changes in cell centroid or nuclear velocities in MC3T3-E1 cells upon optoPlexin
stimulation (Figure 30c,32). By contrast, whole cell illumination of optoPlexinexpressing cells led to collapse of all existing protrusions and hindered motility
(Movie 14), similar to the response on bath application Sema4D-Fc (Figure 16a, b).
Thus, localized Plexin-B1 signaling through optoPlexin stimulation revealed a CILlike phenotype in MC3T3-E1 cells that had not been demonstrated previously.
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Figure 29. OptoPlexin induces CIL upon local activation. MC3T3-E1 cells
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Figure 30. Effects of local activation of optoPlexin on cell morphology and motility.
Effects on the illuminated protrusions (a), measured in a 50 μm diameter circle
centered at the region of illumination, and total cell areas (b) after 7.5 minutes of
local illumination in MC3T3-E1 cells expressing Cry2, optoPlexin, optoPlexin-delPBD,
optoPlexin and pretreated with 10 μM Y-27632 ROCK inhibitor, and optoPlexin-RA, n
= 9-14 cells. (c) Cell centroid velocities at different times upon local activation of
optoPlexin in MC3T3-E1 cells. Blue line, illumination at 440 nm, n = 21 cells. (d) The
locally induced retraction (blue) and the distal protrusion (red) after pulses of
illumination (yellow) of an optoPlexin-expressing cell was illustrated in a morphology
diagram. The overlapping cell area before and after illumination was labeled in
green. Based on the centroids of these color-coded regions, θ1 and θ2 were used to
describe the angles of retraction and protrusion relative to the direction from the
centroid of the cell at time 0 to the center of illumination, respectively. Similarly, d1
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(e), (f) Angles of retraction and protrusion induced by local activation of optoPlexin in
MC3T3-E1 cells and (g) standard deviation of their distribution, n = 14 cells. (h)
Proximity of retractions and protrusions induced by local activation of optoPlexin in
MC3T3-E1 cells to the region of illumination, n = 14 cells. For a, b, c & h, means ±
s.e.m are shown, *** p<0.001, * p<0.05, NS, not significant, Student’s t-test. For g,
*** p<0.001, * p<0.05, NS, not significant, F-test.
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Both RhoA and RasGAP pathways are required for CIL
To determine which pathway(s) downstream of optoPlexin mediates CIL, we
quantified the changes in protusive areas induced by optoPlexin activation. We
already showed that the delPBD mutant failed to inhibit protrusion (Figure 29b,
30a, Supplementary Movie 13). A specific ROCK inhibitor Y-27632 also abrogated
optoPlexin mediated retractions (Figure 30a), further validating the role of RhoAROCK signaling in Plexin-B1 mediated retractions. In addition, we tracked the
signaling molecules upstream or downstream of RhoA. We locally activated
mCherry-optoPlexin in cells coexpressing mVenus-PRG, and found PRG was
recruited immediately to the spot where optoPlexin accumulated (Figure 33a,
Movie 15). The line-scan profile of PRG resembled that of optoPlexin very closely
(Figure 33b), which is consistent with a physical interaction between these two
proteins. Myosin II regulatory light chain (MyoRLC) is phosphorylated by ROCK
downstream of RhoA, which leads to its association with actin filaments. We used
mCherry-MyoRLC in TIRF imaging to track the immobilized myoRLC as an
indicator of myosin II activation151. Upon local activation of mVenus-optoPlexin, we
observed accumulation of mCherry-myoRLC at the site of illumination, but with an
apparent delay (Figure 33c, d, Supplementary Movie 16). Interestingly, the distal
protrusions induced were associated with substantially decreased myoRLC,
suggesting a depletion of myosin activity in these nascent protrusions (Figure 33c,
e). An optoPlexin mutant (optoPlexin-RA) (Figure 21) lacking RasGAP activity also
failed to induce retraction (Figure 30a, 34, Supplementary Movie 17). The
response of MC3T3-E1 cells upon local activation of optoPlexin-YF mutant was
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indistinguishable from that of optoPlexin (Figure 30a, 35, Supplementary Movie
18). In all cases where retraction was not induced, protusions also failed to form in
distal regions. Thus both RhoA and RasGAP pathways are required for optoPlexin
to induce CIL.
Local activation of optoPlexin repolarizes PIP3
Phosphoinositides, in particular phosphatidylinositol(3,4,5)P3 (PIP3), are
extensively involved in regulation of cell polarity and motility152,153. To examine
whether PIP3 is regulated in migration of MC3T3-E1 cells, we employed the PH
domain of Akt (PH-Akt) to monitor the spatial distribution of PIP351. Ratiometric
imaging of mVenus-PH-Akt and a cytosolic mCerulean volume maker were imaged
using TIRF microscopy and their ratio (mVenus/mCerulean) was used to indicate
the levels of PIP3 enrichment. Consistent with a role of PIP3 in migration, we
observed accumulation of PIP3 at the leading edge and low levels in retracting
areas of migrating MC3T3-E1 cells (Figure 36a, b). Because of the overlapping
wavelengths between optoPlexin activation and mCerulean excitation, to
investigate spatial regulation of PIP3 during optoPlexin mediated CIL, we activated
mCherry-optoPlexin at protrusions first and acquired a pair of mVenus and
mCerulean images upon induction of distal protrusions. In contrast to an elevated
PIP3 seen in unperturbed protrusions, a substantial reduction of PIP3 was
observed in the area of optogenetic illumination. Furthermore, we observed an
acute accumulation of PH-Akt in the newly formed distal protrusions (Figure 36c,
d). Neither optoPlexin-delPBD nor optoPlexin-RA induced significant decrease of
local PIP3 (Figure 36d) upon at least 7.5 minutes of local activation. Thus our data

83

supported the requirement of both RhoA activation and RasGAP activity of PlexinB1 in regulating PIP3 in osteoblasts.
OptoPlexin spatially coordinates Cdc42 activity in CIL
Small GTPases Rac1 and Cdc42 are potent inducers of actin polymerization
and migration. Employing Dora-Cdc42 and Dora-Rac1 biosensors154, we observed
elevated Cdc42 activation at protrusions in migrating MC3T3-E1 cells, whereas
Rac1 activity was less polarized (Figure 37). To examine how optoPlexin may
affect Cdc42 and Rac1 activities, we co-expressed mCherry-optoPlexin with a
Dora-Cdc42 or Dora-Rac1 sensor in MC3T3-E1 cells. We activated optoPlexin
exclusively in a protrusion where Cdc42 was expected to be active. In order to
avoid activating optoPlexin globally, we acquired sensor images when distal
protrusion(s) were induced (Figure 38a, b). We did not detect any active Cdc42 in
the illuminated and retracting area, suggesting local inhibition of Cdc42 activity
(Figure 38b, e). In contrast, the new protrusions in distal regions showed marked
activation of Cdc42. Moreover, a non-binding control sensor exhibited low ratio
values and minimal variation across the cell (Figure 38c-e), suggesting that the
Cdc42 polarization was not due to a volume artifact. Using the Dora-Rac1 sensor,
we found that Rac1 was also activated in the distal protrusion(s), albeit to a
substantially reduced level (Figure 38e, 39). Thus, our data indicated that spatial
and temporal activation of Cdc42 and possibly Rac1 may coordinate the opposing
effects between local and distal regions upon optoPlexin activation.
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Figure 33. OptoPlexin induces CIL through RhoA mediated pathways. (a) TIRF
images showing localized membrane recruitment of mVenus-PRG with mCherryoptoPlexin in MC3T3-E1 cells upon local illumination. White circle, region of
illumination. Scale bar, 10 μm. (b) Normalized intensities of mCherry-optoPlexin
and mVenus-PRG after local illumination in a linescan analysis. Reference line for
the linescan is shown in the right top panel of (a). (c) TIRF images showing a
polarized distribution of mCherry-MyoRLC upon local activation of mVenusoptoPlexin in MC3T3-E1 cells. White circle, region of illumination. Asterisk,
induced retraction. Arrowhead, induced protrusion. Scale bar = 10 μm. (d)
Temporal changes in average mCherry-MyoRLC intensity in a 50 μm diameter
circle around the region of illumination (white circle) in MC3T3-E1 cells upon
localized activation of mVenus-optoPlexin. Red and green circles indicate t1/2 for
optoPlexin and RhoA inductions respectively as estimated from Fig. S4b. Blue line,
illumination at 440 nm. (e) Relative intensities of mCherry-MyoRLC in retractions
and new protrusions induced by local activation of mVenus-optoPlexin,
normalized to the whole cell average. For (d) and (e) n = 12 cells, means ± s.e.m.
*** p<0.001, * p<0.05, NS, not significant, Student’s t-test.
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OptoPlexin redistributes β-Pix to distal regions during CIL
To understand how optoPlexin may regulate Cdc42 and Rac1, we focused
on a ubiquitously expressed RhoGEF β-Pix, which activates Cdc42 and Rac1155,156
and mediates crosstalk between RhoA and Cdc42/Rac1. In migrating MC3T3-E1
cells, β-Pix is predominantly associated with nascent adhesions and focal
complexes in protrusions rather than with focal adhesions in stationary or retracting
areas (Figure 40 a-c). Consistent with previous reports157, inhibition of RhoAROCK signaling using ROCK inhibitor Y-27632 promoted association of β-Pix with
adhesions (Figure 40d). To examine how optoPlexin may affect β-Pix locally, we
co-expressed mVenus-Venus-fecmCherry-Paxillin with optoPlexin in MC3T3-E1
cells and tracked their changes upon optoPlexin activation in separate
experiments. Upon activating optoPlexin, β-Pix was rapidly depleted in illuminated
region (Figure 41a, b top panel, 42a, Supplementary Movie 19). This depletion was
not due to a loss of adhesions as we observed an increase in the intensity of
paxillin around sites of illumination (Figure 41c, d top panel, 42b, Supplementary
Movie 20). The opposite changes in β-Pix and paxillin accumulation indicate
dissociation of β-Pix from the adhesion molecular complex (Figure 41e, 42). The
decrease of β-Pix around the region of illumination preceded or coincided with the
initiation of retraction (Figure 41b top panel, 42c). Moreover, we observed a
concurrent accumulation of β-Pix and nascent adhesions in distal regions where
new protrusions were produced (Figure 41b, d bottom panels). In support of the
involvement of RhoA signaling, optoPlexin-delPBD failed to deplete β-Pix locally,
and addition of ROCK inhibitor Y-27632 also abrogated the effects of optoPlexin
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on Plexin on β-Pix redistribution (Figure 41f, 43). The presence of exogenous β-Pix
caused a delay in retraction that was proportional to the level of β-Pix expression
(Figure 41g), suggesting that a local depletion of β-Pix may be required for the
initiation of retraction. Taken together, these data revealed a novel mechanism in
which a redistribution of β-Pix mediated by Plexin-B1-RhoA pathway coordinates
CIL.
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Discussion:
Semaphorin-Plexin signaling attracts a lot of research interest because of its
important functions in development and diseases. In vivo semaphorins are often
present as directional cues for cell migration, and thus experimental perturbations
with spatial control at the subcellular scale can offer unique insight into their
signaling mechanisms. One of the technical challenges in spatial control is that
existing ligand-based methods may not be optimal for localized stimulation. Here
we describe a novel approach to precisely control the location and time of PlexinB1 activation with light. We validated this new optogenetic reagent by tracking its
binding with two known interacting RhoGEFs, PRG and LARG, and by visualizing
its activation of RhoA. We named the new tool optoPlexin, following the naming
convention of many optogentic reagents developed in recent years158–161. To our
knowledge, optoPlexin is the first optogenetic tool for the receptors of repulsive
guidance molecules.
The optogenetic module Cry2 has two independent134 modes of action, i.e.
inducible translocation mediated by CIB1132 and homo-oligomerization133, which
benefitted optoPlexin design to reduce dark background. We found that mere
oligomerization (by omitting CIB-CAAX) is not sufficient for inducing binding of
PRG, a GEF for RhoA (Figure 26d,e) or RhoA activation (Figure 26g). It is likely
that additional factors such as Rnd1 or Rac1 on the plasma membrane may
participate in recruiting PRG63,69,70. Additionally, the slow off-rate of Cry2-CIB1
binding helped to maintain the Plexin-RhoGEF complex locally, mimicking
sustained contact between osteoblasts and osteoclasts. Using optoPlexin, we
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demonstrated spatial modulation of different regulators of cell migration to
understand the signaling mechanism involved in CIL between osteoclasts and
osteoblasts. Since plexins share high sequence homology in their intracellular
regions62, optoPlexin design should be extendable to other plexins as well.
Upon Sema4D stimulation ErbB2 associates with and is transactivated by
Plexin-B1 and regulates RhoA activation through Phospholipase C-γ(PLC-γ)86,149.
Given that the interaction with ErbB2 is mediated by the extracellular domain of
Plexin-B1, it is unlikely that optoPlexin can associate with or activate ErbB2, which
could be a limitation of optoPlexin. However, clustering of the cytosolic domain of
Plexin-B1 on the membrane was shown to be sufficient for RhoA activation141. Our
results also demonstrated that optoPlexin sufficiently recruits RhoGEF and
activates RhoA. Mutations designed to abrogate PLC-γ association (optoPlexinYF) did not affect RhoGEF recruitment, RhoA activation or the repulsion phenotype
induced by optoPlexin. It is possible that ErbB2 mediated tyrosine phosphorylation
of Plexin-B1 and consequent association with PLC-γ promotes clustering of the
endogenous protein, which is compensated by light induced clustering of
optoPlexin.
In interrogating Plexin-B1 signaling, we probed the RhoA-ROCK-Myosin
pathway, and observed accumulation of MyoRLC and maturation of nascent
adhesions in the protrusions where optoPlexin was activated. Local activation of
optoPlexin repolarized active Cdc42 and active Rac1 away from the retracting
area to new distal protrusions. We attribute these effects to mobilization and a
redistribution of β-Pix. Crosstalk among Rho GTPases are known to facilitate cell
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migration and polarity55. β-Pix is one of the molecules that mediate cross-talk
between RhoA and Cdc42 or Rac1. Myosin II-mediated contractility, downstream
of RhoA/ROCK signaling, has been shown to induce dissociation of β-Pix from
adhesions and decrease Rac1 activation157. While we identified RhoA/ROCK
activity being critical for local depletion of β-Pix, the exact molecular mechanism
by which β-Pix is regulated demands further investigation. Our observations of
opposite repolarization of MyoRLC and adhesion maturation compared to β-Pix
are consistent with a model of mechanical regulation, although we cannot rule
out a role of ROCK mediated phosphorylation of β-Pix155,162 in its redistribution.
Importantly, localized Plexin-B1 signaling did not simply deplete β-Pix, but
induced redistribution to distal regions and activated Cdc42 and Rac1 to promote
new protrusions. While we also observed repolarization of PIP3, the underlying
signaling mechanism remains to be explored. Plexin-B1 may inhibit PIP3 by
activating Phosphatase and tensin homolog (PTEN) via its RasGAP domain163.
RhoA activation by Plexin-B1 may also activate PTEN and SH2 domain
containing inositol 5’-phosphatase 2 (SHIP2)57,164. In other studies, Plexin-B1 has
been reported to promote PIP3 production through activation of phosphoinositide
3-kinases (PI3Ks)90,165. R-Ras is another important target that regulates CIL, as
evident from the inability of optoPlexin-RA to induce CIL or PIP3 redistribution. All
plexins contain a RasGAP domain16,56 and other repulsive guidance molecules
such as ephrins also inhibit R-Ras65,66, suggesting that R-Ras may play a critical
role in mediating repulsion between cells.
Optogentic approach offers spatial and temporal control in initiating

100

signaling pathways in subcellular regions. This is particularly lucrative in studying
CIL since the underlying signaling is initiated specifically at the site of cell-cell
contact. Precise activation of optoPlexin in leading protrusions steered MC3T3E1 cells away in a manner reminiscent of osteoclast-mediated CIL and followed
similar timelines of retractions and protrusions (Figure 41h). While CIL has been
proposed to transiently promote cell motility166, both osteoclasts and localized
optoPlexin stimulation induced CIL without affecting the overall motility of
MC3T3-E1 cells (Figure 13b, 30c, 32). Previous studies have reported formation
of transient cadherin-mediated cell-cell adhesions that generate mechanical
tension across cells undergoing CIL47,56,59,167,168. We observed a sustained
contact between osteoclasts and osteoblastic cells before separation
(Supplementary Movie 2, 3, 5), which may potentially be critical for Plexin-B1
clustering. Whether osteoblasts and osteoclasts form any cadherin-mediated
inter-cellular adhesions and their role in heterotypic CIL remains to be
investigated. Our experiments with optoPlexin cannot decipher the nature and
duration of such cell-cell contact. Nevertheless, we observed cellular response
comparable to CIL induced by osteoclasts with similar kinetics (Figure 41h),
suggesting that localized activation of Plexin-B1 was sufficient to generate similar
behavior. Furthermore, our observations on spatial redistribution of PIP3, active
Cdc42 and active Rac1 suggest that although different signaling mechanisms
may initiate homotypic and heterotypic CIL, their effects converge to induce
similar spatial changes in factors that regulate cell migration.
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In recent years, repulsion between cells has been implicated in many
physiological and pathological processes37. Our data demonstrate CIL between
osteoblasts and osteoclast. In the bone microenvironment, resorption by
osteoclasts is followed by deposition of matrix by osteoblasts. Osteoclasts are
generally thought to attract osteoblasts to the site of resorption through release of
chemoattractants8,9,144,145. However, a simple chemotaxis model does not explain
spatial segregation of osteoclasts and osteoblasts on the bone surface15, which is
consistent with their opposing functions. Our observation of CIL between
osteoclasts and osteoblasts explains the spatial segregation between osteoblasts
and osteoclasts15,58. Additionally, loss of Sema4D has been reported to impact
bone resorption119. Whether osteoclasts utilize similar signaling mechanisms to
repel osteoblastic bone lining cells and gain access to the bone matrix to initiate
resorption remains to be investigated. A combination of CIL and chemotaxis might
facilitate osteoblasts occupying sites of resorption only after the short-lived
osteoclasts disappear. Considering the multitude of coupling factors between
osteoclasts and osteoblasts, further research is necessary to gain a complete
understanding of how osteoclasts modulate osteoblast migration and function.
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Materials and methods
Cell culture and transfection Primary calvarial osteoblasts (POB) were obtained
as described previously169 from two month old inbred C57BL/6 male mice. Briefly,
calvariae from 5-6 neonatal mice were minced, washed with Phosphate-buffered
saline (PBS) and digested with 0.5 mg/ml collagenase P (Roche Diagnostics,
Indianapolis, IN) and 0.5 mg/ml Trypsin/EDTA in PBS at 37°C four times for 10
minutes each and a final digest for 90 minutes. Cells isolated from digests 2-5
were combined and plated at a cell density of 4 × 104 cells/well in 6 well dishes for
imaging experiments. For coculture experiments, POBs were lifted at day 5-7 after
isolation. For real-time quantitative PCR, MC3T3-E1 and POBs were plated at

5X104 cells /well in 6-well dishes and cultured in osteoblast differentiation media for
7 or 14 days. Osteoblast differentiation medium consisted of basic medium plus 50
µg/ml phosphoascorbate (Wako Pure Chemical Industry, Osaka, Japan). Media
were changed every 3 days. 5 mM of β-glycerophosphate (Sigma-Aldrich, SaintLouis, MO) was added on day 7 of these cultures. Bone marrow macrophages
(BMMs) were made as described previously169 following the protocols of R. Faccio
(www.orthoresearch.wustl.edu/content/Laboratories/2978/Roberta-Faccio/FaccioLab/Protocols.aspx) from 5-6 two month old inbred C57BL/6 and outbred CD1
male mice. For osteoclastic differentiation, recombinant mouse macrophagecolony stimulating factor (M-CSF) and receptor activator of nuclear factor κ B
ligand (RANKL) were purchased from R & D systems (Minneapolis, MN, USA).
BMMs were plated at 6X104 cells/well in 12-well dishes in basic medium plus 30
ng/ml M-CSF with or without RANKL (30 ng/ml) for 3 days. Vehicle for RANKL and
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M-CSF was 0.1% bovine serum albumin (BSA) in phosphate buffered saline
(PBS).
All studies were conducted in accordance to the approved protocols by the
Institutional Animal Care and Use Committee of the University of Connecticut
Health Center.
COS-7 and MC3T3-E1 cells were obtained from American Type Culture
Collection (ATCC) and were cultured in DMEM and α-MEM (Lonza, Basel,
Switzerland) basal media respectively, and were passaged every third day of
culture. For optimal growth, the media were supplemented with 10% (v/v) FBS
(Gibco, Billings, MO) and Penicillin/Streptomycin (Lonza), and the cells were
maintained under standard cell culture conditions (37°C and 5% CO2). The cell
lines were regularly checked for mycoplasma contamination. FuGENE 6 reagent
(Promega, Madison, WI) was used for transient transfections according to
manufacturer’s instructions. Lentiviral transductions for shRNA and CRISPRCas9 approaches were performed as previously described.
DNA plasmids pLKO.1 puro vector (Addgene plasmid # 8453) was a gift from Dr.
Bob Weinberg. lentiGuide-Puro (Addgene plasmid # 52963) and lentiCas9-Blast
(Addgene plasmid # 52962) were gifts from Dr. Feng Zhang (Massachusetts
Institute of Technology, Cambridge). The farnesylated CIB (CIB-CAAX) and fulllength Cry2 expression plasmids (same as addgene plasmids 28240 and 26871
respectively) were gifts from Dr. Chandra Tucker (University of Colorado, Denver).
The source cDNAs of mouse Plexin-B1, Plexin-B1-RA, and Plexin-B1-delPBD (Fig.
S1) were from Dr. Hiroshi Takayanagi (Tokyo Medical and Dental University,
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Japan). The cDNAs of PRG and LARG were from Dr. Keith Burridge (University of
North Carolina at Chapel Hill), of PRG and LHordijk (University of Amsterdam, the
Netherlands), myosin regulatory light chain (MRLC) from Dr. Rex Chisholm
(Northwestern University), and PH-Akt from Dr. Craig Montel (University of
California,Santa Barbara). These constructs were initially subcloned into the
pTriEx-4 vector (Novagen) using polymerase chain reaction (PCR) and restriction
digestion. Cry2 was positioned at the N-terminus and Plexin-B1 at the C-terminus
to minimize interference with PRG and LARG. As indicated in the results and figure
legends, tags of compatible fluorescent proteins including mCerulean, mVenus and
mCherry were appended to facilitate detection. Unless specified otherwise, the
termini of tagging were positioned as in the orders they were written. Additional
point mutations in the Cry2, D387A and D393A, were generated using overlapping
PCR. The open reading frames of all DNA plasmids were verified by DNA
sequencing.
Co-culture migration assay Cell culture inserts (Ibidi, Germany) were used
according to manufacturer’s instructions. Briefly, the culture inserts were placed
on tissue culture dishes and BMMs were cultured and differentiated into
osteoclasts inside one of the insert chambers. Upon appearance of
multinucleated osteoclasts, osteoblasts or MC3T3-E1 cells were added to the
empty adjacent chamber. After 5-6 hours of incubation allowing the cells to
adhere to the tissue culture dish, the inserts were gently lifted using tweezers
enabling the cells to migrate towards the osteoclasts. Delay in retraction and
protrusions upon contact were determined by visual inspection. Initiation of
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retraction was identified as the time point when a protrusion in contact with
osteoclasts began to contract. Initiation of protrusions was identified as the time
point of formation of the persistent protrusions that enabled the cell to migrate
away from the site of contact. Cell velocities were computed by measuring the
displacement of the cell nuclei.
Quantification of CIL Whether a protrusion collapsed at the site of cell-cell
contact was determined by visual inspection using time lapse images within 30
minutes after contact. Previous studies have quantified CIL by measuring spatial
separation between cells undergoing CIL42,47,59. Since osteoclasts are large cells
with multiple nuclei, we determined the spatial separation between osteoclasts
and osteoblasts by computing the difference in distances between the
osteoblastic nucleus and the site of contact at the time of and 40 minutes after
contact. Positive and negative values respectively indicate spatial separation or
lack of it. Changes in direction of migration of osteoblasts after contact were
assessed by measuring contact acceleration indices (Cx) using vector analyses
as described previously42–44. Briefly, the displacement of a migrating osteoblast
for 40 min before contact (vector A) and 40 min after contact (vector B) were
determined by tracking the nuclei. The Cx component of the vector (B-A) is a
measure of how much the cell has deviated from its original trajectory (vector A’)
in the migration axis after contact (Figure 12h). Cx values for MC3T3-E1 cells
that did not come in contact with osteoclasts were also determined for 40 minute
intervals. Positive and negative values of Cx respectively indicate persistence
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and reversal of direction of motion. In the absence of CIL, Cx approaches zero,
whereas higher magnitudes indicate significant deviation from expected path.
Real-time quantitative PCR Total RNA was extracted using Trizol (Invitrogen)
following manufacturer’s instructions. 4 μg of total RNA was DNase treated
(Ambion Inc., Austin, TX) and converted to cDNA by the High Capacity cDNA
Archive Kit (Applied Biosystems, Foster City, CA). PCR was performed in 96-well
plates. Assays-on-Demand Gene Expression Taqman primers (Applied
Biosystems) were used for PCR (Mm99999915_g1 for Gapdh; Mm00443147_m1
for Sema4d; Mm00555359_m1 for Plxnb1). Gapdh served as endogenous
control. All primers were checked for equal efficiency over a range of target gene
concentrations. Each sample was amplified in duplicate. PCR reaction mixture
was run in Applied Biosystems Prism 7300 Sequence Detection System
instrument utilizing universal thermal cycling parameters. Data analysis was done
using relative quantification (RQ, ΔΔCt) or the relative standard curve method.
As per manufacturer’s recommendation, any cycle threshold (Ct) values obtained
below 33 were considered undetectable for that particular target gene.
Western blot analysis MC3T3-E1 and POBs prior and after addition of βglycerophosphate were washed three times with phosphate-buffered saline, and
lysed on ice in a buffer containing 1% Triton X-100, 50 mM monobasic sodium
phosphate (pH 7.4), 150 mM NaCl, 5 mM EDTA and HaltTM Protease inhibitor
cocktail (Thermo Scientific, Rockford, IL, USA). The cell lysates were fractionated
using 4-12% NuPAGE gels (Invitrogen), immobilized on to PVDF membranes
(Millipore), followed by immunoblotting using anti-Plexin-B1 monoclonal antibody
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(A-8, Santa Cruz Biotechnology, Dallas, TX, USA) or anti-alpha-tubulin
monoclonal antibody (DM1A, Cedarlane laboratories, Burlington, Ontario,
Canada) and horseradish peroxidase-coupled secondary antibody (Millipore,
Germany). Enhanced chemiluminescence detection (Pierce, Waltham, MA, USA)
and autoradiography were used to detect the signals. For detection of Sema4DFc horseradish peroxidase-coupled Protein-A was used. The blot images were
cropped to show relevant bands. For Figure 12c, the uncropped scan is shown in
Figure 44.
RNAi approaches and CRISPR-Cas9 mediated Plexin-B1 knock out
siGENOME non-targeting (D-001206-13-05) and Plexin-B1 (M-040982-01-0005)
siRNA pools (GE Dharmacon, Colorado, USA) were used according to
manufacturer’s instructions.
shRNA target sequences for luciferase (Luc, TRCN0000072254 ) and
Plexin-B1 (sh1 - TRCN0000078913, sh2 - TRCN0000078917 and sh3 TRCN0000078916) were identified using Broad Institute Genetic Perturbation
Platform web portal (http://broadinstitute.org) and were cloned into pLKO.1 puro
vector.
To identify target sites for CRSPR-Cas9 mediated knock-out, the genetic
sequence of Plexin-B1 was obtained from UCSC genome browser
(http://genome.ucsc.edu) using the mouse assembly GRCm38/mm10
(December, 2011). The gene encoding Plexin-B1 has 38 exons, with the start
codon located within the third exon. Two sgRNAs were designed flanking the
start codon (Figure 14f,Table 1) using CRISPR design tool by Zhang lab
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(http://crispr.mit.edu) so that Cas9 mediated cleavage was expected to delete a
100 bp region including the start codon. The sgRNAs were cloned into
lentiGuide-Puro vector68. Cas9 and the sgRNAs were stably expressed in
MC3T3-E1 cells using lentiviral transduction. Genomic DNA from 24 clones of
the transduced MC3T3-E1 cells were extracted using Quick-gDNATM kit (Zymo
Research, Irvine, CA, USA) as per manufacturer’s instructions. Upon PCR
screening we identified two clones that showed deletion at the expected site
(Figure 14g, Table 1). DNA sequencing validated the loss of Plexin-B1 start
codon in both of these clones. Loss of Plexin-B1 expression was further
confirmed using western blot (Figure 12d).
Immobilization of Sema4D-Fc and IgG1 on silica beads Sema4D-Fc and
hIgG1 were immobilized on 5 μm diameter Silica Bind-ITTM pre-activated
microspheres (Catalog # SB06N) from Bangs Laboratories (Fishers, IN, USA) by
following the manufacturer’s instructions with minor modifications. Briefly, 50 μl of
the 2.5% bead suspension was centrifuged at 1000 X G for 5 minutes. The
supernatant was removed and the beads were washed thrice in 100 μl coupling
buffer (50 mM MES buffer, pH 5.2). After the final wash, the supernatant was
removed and 25 μl coupling buffer. 25 μl of Sema4D or hIgG1 solution (0.1
μg/ml) were added to the bead suspension and incubated for 2 hours at 4 ̊C for 2
hours on a rotator. The suspensions were centrifuged, the supernatant was
removed and the beads were washed thrice in 100 μl storage solution (150 mM
NaCl, pH 7.0). After the final wash, the beads were resuspended in 50 μl storage
solution and this suspension was used for further experiments. To assess the
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Figure 44. Full blot for Figure 12c.
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amount of Sema4D immobilized on the beads, western blot was performed under
non-reducing conditions. The samples 1X and 1/10X dilutions were equivalent to
25 μl and 2.5 μl of the bead suspension. From the western blot (Supplementary
Figure 20d, e) we estimated that 80.5 ng Sema4D-Fc was present in the 1/10X
sample. The density of the beads as provided by the manufacturer is 2g/cm3.
Assuming no loss of beads or Sema4D-Fc during the sample preparation and
assuming perfectly spherical beads, we calculated that the average number of
Sema4D-Fc molecules bound to each silica bead was around 1000. Assuming a
hemispheric contact (Figure 20f), each bead would provide 500 Sema4D-Fc
molecules to come in contact with the cells. Furthermore, an even distribution of
Sema4D-Fc is equivalent to a surface density of 12.73 molecules/μm2, which
amounts to a distance of 280 nm between each molecule (Figure 20g). It is
possible that by using a significantly higher surface density of Sema4D-Fc, or
enabling diffusion of Sema4D-Fc on such beads by using lipid layers may solve
this problem; however such approaches would still not allow sufficient spatial and
temporal control since it is difficult to manipulate the specific time and location of
contact between cells and the beads.
Imaging setup. All time-lapse imaging were performed on a customized Nikon
Ti-E inverted microscope. Phase contrast images for osteoclast co-culture
experiments were captured using a 10x objective (NA 0.30) and Andor Neo 5.5
sCMOS camera. Wide field fluorescence imaging was performed using 40x oil
objective (NA 1.30) using LED sources for excitations at 438, 513 and 575 nm
(CoolLED) for imaging mCerulean, mVenus, and mCherry respectively. TIRF
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imaging was performed using a 60x oil TIRF objective (NA 1.49). The
microscope was modified with a “stage-up” design which enables an insertion of
two independent, motorized dichroic mirrors/filter cubes in the microscope infinity
space. A dichroic mirror in the bottom cube was used to reflect excitation laser
lines at 442, 514, 594 nm for imaging of mCerulean, mVenus, and mCherry
respectively. The laser lines were lunched from a fiber-coupled LMM5 system
(Andor) equipped with an acousto-optic tunable filter (AOTF) for shutter and
intensity control. Another dichroic mirror (495LP) in the top cube was used to
bring in optogenetic illumination originated from a LED source at 440 nm
(CoolLED). The 495LP mirror permitted immediate acquisition of mVenus or
mCherry after optogenetic illumination. Alternatively, the top mirror can be
rotated out to a blank position for Patterned illumination was generated using a
commercial digital mirror device (Mosaic, Andor). The fluorescent emission was
captured with an EMCCD camera (iXon Ultra, Andor). Metamorph software was
used to control the imaging set up. Live cell imaging was performed at 37°C in a
heated chamber (Bioptechs) with humidified 5% CO2 supply. Vitamin and phenol
red-free media (US Biological) supplemented with 2% FBS were used in imaging
to reduce background and photobleaching.
Membrane recruitment assay COS-7 or MC3T3-E1 cells were transiently
transfected with mVenus- or mCherry-optoPlexin along with CIB-CAAX. The
recruitment of optoPlexin to the plasma membrane was induced with a short pulse
(50 ms) 440 nm illumination at 10 s intervals, shortly (typically 10-15 frames) after
acquisition of base lines of fluorescent intensities. For localized activation, a 5 μa-

112

diameter circular region near the cell periphery was chosen for each cell. TIRF
imaging of mVenus and/or mCherry channel was used to gauge the amount of
optoPlexin that became excitable by the evanescent wave (~200 nm from the
coverslip surface) presumably due to association with the plasma membrane.
Because a robust translocation of optoPlexin could be induced in the assay (Fig.
1c), proteins associated with optoPlexin, labeled with different fluorescent proteins
for example, mVenus-PRG and mCherry-optoPlexin for example, may also
‘precipitate’ into the TIRF imaging plane due to association. After conducting
background subtraction using the mean fluorescence intensities of cell-free
regions, the fluorescence intensities after 10 blue light pulses were normalized to
that before blue light illumination, and the changes were used to estimate the
recruitment of optoPlexin and its associated proteins to the plasma membrane.
The results of membrane recruitment assay were quantified as follows,
𝑅" =

∆𝐹& (𝑚𝑉𝑒𝑛𝑢𝑠)
𝐹
∆𝐹& (𝑚𝐶ℎ𝑒𝑟𝑟𝑦)
𝐹

where RC = relative co-recruitment and F = fluorescence intensity.
To minimize effects of noise in measurement of binding, only cells with at least
30% fractional increase in optoPlexin signal were considered.
Quantification of optoPlexin clustering The local variance of fluorescence
intensities was used to estimate the extent of molecular clustering of optoPlexin
and its associated proteins. Briefly, TIRF imaging was used to sample the basal
focal plane of cell, thereby rejecting most of the out-of-focus fluorescence. The raw
images were first background subtracted using cell-free regions. To eliminate
effects of changes in cell topology on changes in variance of fluorescence
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intensities, a ratio image was then calculated using the original image divided by a
processed one, which was passed through an empirically determined 5x5 median
filter. Clustering index was defined as the fractional changes in standard deviation
of the ratiometric image (Figure 25).
Analysis of cell repolarization Fluorescence images of MC3T3-E1 cells
expressing optoPlexin (or its mutants) were thresholded based on intensity to
produce binary images. Cell velocity at each frame was measured by tracking the
displacement of the centroids of these binary images, and average of such
velocities was used to assess the cell velocity. Changes in cell shape were
identified by subtracting the binary images in a time series from the image at time
0. Pixels of areas in positive values were identified as protrusions. Conversely
ones in negative values were identified as retractions. Areas where the images
overlapped since time 0 were designated as neutral regions. An arbitrary floor was
added to the image to display these regions in color: red for protrusion, blue for
retractions and green for regions occupied by the cell at both time points, whereas
cell free regions were shown in white. The region of blue light illumination is shown
in yellow (Figure 30d). Only regions exceeding 50 pixels (3.52 μm2) were
considered in the quantification of protrusions and retractions, and only regions
that were converted from protrusions to retractions were used to measure
induction of retractions by optoPlexin.
To measure the angle of retraction (θ1) or protrusion (θ2) with respect to the
region of illumination, a straight line joining the centroid of the cell at time 0 was
used as the horizontal axis. The angle between the straight line joining the centroid
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of protrusions (or retractions) and the centroid of the cell at time 0 and the
horizontal axis was defined as the angle of protrusion (or retraction). The proximity
of retraction (d1) and protrusion (d2) to the region of illumination was measured by
the linear distance between the centroid of protrusion (or retraction) and the
centroid of the region of illumination. Delay in initiation of retraction was
determined by identifying the time point when the cell area in a 50 μm diameter
circle centered around the region of illumination (as defined for Figure 30d) began
to contract. Metamorph (Molecular Devices, Sunnyvale, CA) and Matlab
(Mathworks, Natick, MA) softwares were used for image processing and data
analyses.
Imaging and analysis of FRET sensors For FRET imaging, donor (mCerulean)
images were captured sequentially after the FRET (mVenus) image. The DoraRhoA sensor uses an intra-molecular effector fragment derived from the RhoA
effector Protein Kinase N (PKN) to detect the nucleotide states (GDP or GTP) of
RhoA. Upon GTP-loading or activation of RhoA, Dora-RhoA interacts with the
effector fragment and adopts a closed conformation. The conformational change
leads to an increase of FRET signal, the extent of which is quantifiable using the
ratio of FRET/CFP. For RhoA sensor imaging in MC3T3-E1 cells upon Sema4D-Fc
or hIgG1 treatment mCerulean and FRET images were acquired every minute. For
RhoA sensor imaging in COS-7 cells on optoPlexin activation, sequential images
of mCherry, mCerulean and FRET images were acquired every 10 s using TIRF
excitation with 594 nm and 442 nm lasers. Since the excitation wavelength for CFP
and FRET was sufficient to activate Cry2 recruitment, no additional blue light
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illumination was employed. Ratiometric images of FRET and mCerulean were
generated and changes in the average intensity of these ratiometric images were
used to measure changes in RhoA activity. The first image in each of these time
series was used for baseline measurement of RhoA activity before optoPlexin
activation. Changes in ratiometric measurements for a binding deficient RhoA
control sensor in response to mCherry tagged Cry2 recruitment was used to
correct for optical artifacts of mCherry and Cry2 recruitment to the TIRF plane.
DORA-Rac1 and DORA-Cdc42 sensors share a similar design as the Dora-RhoA
sensor except using a Cdc42/Rac interactive binding (CRIB) domain of p21activated kinase (PAK) as the binding domain. The non-binding control Cdc42
sensor control harbours a mutated (H83,86D) effector domain in Dora-Cdc42 and
does not alter FRET in response to activation. For Cdc42 sensor, Cdc42 control
sensor and Rac1 sensor imaging in MC3T3-E1 cells, optoPlexin was locally
activated using the Mosaic illumination system as mentioned above until we
observed local retraction and distal protrusions, at which point the time lapse
imaging was ended and FRET and mCerulean images were obtained
immediately afterwards. Ratiometric images from each of these FRET and
mCerulean image pairs were processed as described previously69
and used to visualize the spatial distribution of Rac1 and Cdc42 activities in
individual cells.
Statistical analyses Microsoft Excel and Matlab were used for statistical analyses.
Sample sizes for different experiments were chosen based on the commonly used
range in the field without conducting any statistical power analysis. Normal
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probability plot function of Matlab was utilized to confirm normal distribution of the
data. Similarity of variance across all the groups (or before and after stimulation)
being compared were tested using F-test in Matlab. For RT-PCR data, one way
ANOVA was performed using Sigmaplot 11.0 (Systat Inc., Chicago, IL). Sample
means and standard error of mean was calculated and shown on the graphs. P
values were obtained from one-tailed Students t-test.
Data availability: All relevant data are available in the article and the
supplementary information, or upon request from the authors.
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Chapter III
Molecular mechanisms of Plexin-B-mediated activation of PDZ-RhoGEF
and LARG
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Introduction: As described in Chapter I and II, B-family plexins activate
RhoA through two PDZ-domain containing RhoGEFs, PRG and LARG. These
two RhoGEFs, along with p115, share a regulator of G protein signaling (RGS)like domain and are classified as RGS-RhoGEFs172 (Figure 45). Although it is
largely understood how RGS-RhoGEFs are activated by Ga12/13 of heterotrimeric
G proteins--activated Gα12/13 binds with the RGS domain and stimulates GEF
activity173,174; how the B family of plexins activate PRG and LARG remains
elusive. It is thought that Plexin-B1 interacts with PRG or LARG solely via its Cterminal PDZ-binding motif (PBD). However, the PBD-PDZ interaction has been
proposed to be constitutive and thus cannot explain how the RhoGEF activity is
regulated downstream of Plexin. Previous studies have shown that Rnd1 binding
to the RBD of Plexin promotes PRG recruitment and RhoA activation69,
suggesting that 1) an additional interaction(s) may exist between Plexin-B1 and
PRG and 2) such an interaction may involve or be regulated by the RBD of
Plexin. Here, I will discuss some results from ongoing investigations into these
molecular mechanisms. My data demonstrate that Plexin-B1 RBD acts as an
autoinhibitory domain in PRG recruitment: deletion or mutation of the RBD can
relieve the inhibition. Furthermore, we identify the RGS domain of PRG to play a
critical role in Plexin-B1 binding. Our data sheds new light into the mechanism of
Rac1 regulation of Plexin-B1 signaling and identifies an unexpected role of the
RGS domain in PRG binding to Plexin-B1.
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Results: As discussed in Chapter II, I had developed an optogenetic tool named
optoPlexin to initiate Plexin-B1 signaling upon blue light illumination, which
efficiently recruited PRG and LARG to the plasma membrane. We utilized corecruitment of PRG by optoPlexin to investigate how Rac1 might regulate PRG
recruitment by Plexin-B1 (Figure 46). Consistent with the critical role of PBD-PDZ
interaction, we had observed that an optoPlexin mutant lacking the PBD
(optoPlexin-delPBD) failed to recruit PRG. Another optoPlexin mutant lacking
RasGAP activity (optoPlexin-RA) efficiently recruited PRG, suggesting that
RasGAP activity may not indirectly affect PRG recruitment.
GTPase binding to Plexin-B1-RBD is critical for RasGAP activity and has
been reported to promote PRG recruitment and RhoA activation69,63. To test
whether GTP-loaded Rac1 regulates PRG recruitment by optoPlexin, we coexpressed a constitutively active mutant of Rac1 (caRac1) tethered to mCerulean
with optoPlexin and PRG or LARG. Co-expression of caRac1 significantly
increased recruitment of PRG and LARG by optoPlexin (Figure 47a, b).
Illuminating photoactivatable Rac1 (paRac1) or plasma-membrane recruitment of
Cry2-caRac1 did not recruit PRG to the membrane (Figure 47c). Our
observations indicate that the increased PRG recruitment was not due to direct
association between caRac1 and PRG. These data suggest that Rac1 binding to
Plexin-B1-RBD promotes its interaction with PRG. GTP-Rac1 binds to Plexin-B1RBD and to investigate the role of Plexin-B1 RBD in PRG recruitment, we utilized
a previously described mutation in the RBD domain (optoPlexin-GGA, figure 21)
that is known to destabilize it and abrogate Rac1 binding as well as RasGAP

120

activity62,63,175. Despite the presence of the C-terminal PBD, optoPlexin-GGA
failed to recruit PRG. This defect was not rescued by co-expression of caRac1
(Figure 48a), further excluding the possibility that caRac1 may independently
recruit PRG. We further investigated the role of RBD by utilizing an oncogenic
mutation in the RBD (OptoPlexin-L1799F, figure 21) that was detected in solid
tumours176,177. The L1799F mutation increases the RBD stability, abrogates Rac1
binding, but has no impact on RasGAP function of Plexin-B1176. OptoPlexinL1799F recruited PRG very efficiently, at levels comparable to optoPlexin with
co-expression of caRac1. Co-expression of caRac1 with optoPlexin-L1799F did
not further promote recruitment (Figure 48a). These opposite effects of GGA and
L1799F mutants on PRG recruitment prompted us to speculate that these two
mutants mimic an off and on state of a regulatory switch respectively. We
hypothesized that either the GTPase-bound RBD provided additional binding
sites between Plexin-B1 and PRG, or that it inhibited binding between Plexin-B1
and PRG, with the inhibition relieved upon GTPase binding. To test these two
scenarios, we designed a mutant with deletion of the RBD (optoPlexin-delRBD,
figure 21), speculating that lack of PRG recruitment would support a model of
RBD providing additional binding sites, whereas efficient recruitment would
support the second model. OptoPlexin-delRBD recruited PRG at levels
comparable to WT . Further deletion of a short proline rich region in OptoPlexindelRBD (optoPlexin-delRBD-PRR, figure 21) did not affect PRG recruitment
(Figure 48b).
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Recently, an additional binding site for GTP-Rac1 on Plexin-B1 has been
identified, which if mutated disrupts Rac1 binding as well as RasGAP activity71.
GTPase binding to this secondary site has been proposed to be regulated by the
Plexin-B1 juxtamembrane helix, which facilitates a trimeric Plexin-B1-GTPase
complex upon Sema4D binding. To test whether the juxtamembrane region of
Plexin-B1 could regulate PRG recruitment through the GTPase binding site, we
deleted the juxtamembrane helix in an optoPlexin mutant (optoPlexin-delN, figure
21). OptoPlexin-delN showed neither any defects nor any improvements in PRG
recruitment when compared to WT (Figure 48b). It is possible that optoPlexin
does not undergo the juxtamembrane helix dependent trimerization unlike
endogenous Plexin-B1; or that even if present, Cry2 mediated clustering
overshadows any effects such trimeric conformation may have on PRG
recruitment. Regardless, our observations indicate that the juxtamembrane helix
of Plexin-B1 was not critical for PRG recruitment. Furthermore, this indicates that
the RBD predominantly mediates the effects of GTPase binding to Plexin-B1 on
PRG recruitment.
Plexin-B1 is thought to recruit PRG through a constitutive interaction
between the PBD in Plexin and PDZ domain in PRG68. To examine the
importance of the PDZ-PBD interaction, previously we have shown that
optoPlexin-delPBD failed to recruit PRG or activate RhoA (Figure 26c).
Conversely, we introduced a mutation in the PDZ domain of PRG (V106E) to
disrupt PBD-PDZ interaction (Figure 45). OptoPlexin failed to recruit PDZ(V106E)
indicating that PDZ-PBD interaction is necessary for recruitment. To examine
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Figure 45. Functional domains of PDZ-RhoGEF. Domain organization of PDZRhoGEF and its mutants that were used in this study. FP, fluorescent protein.
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Figure 46. RhoGEF co-recruitment assay. Assay used to probe interaction between
PRG and Plexin-B1

124

Relative
co-recruitment

***

1
0.5
0

LA

PR

G
+c

aR

ac

1

G

2
1.5
1
0.5
0

1.5

LA
R
R
G
G
+c
aR
ac
1

b)

***

PR

Relative
co-recruitment

a)

***

PRG

1
0.75
0.5
0.25
0
-0.25

op
to
Pl
ex
C
ry
in
2ca
R
ac
1
pa
-R
ac
1

Relative
recruitment

c)

Figure 47. Rac1 association with Plexin-B1 promotes RhoGEF recruitment.
Relative co-recruitment of (a) PRG and (b) LARG by optoPlexin with or without
overexpression of caRac1. (c) Relative increase in membrane localization of
mVenus-PRG upon illumination of optoPlexin, Cry2-mCherry-caRac1 or mCer3Pa-Rac1. Note that for (c) pa-Rac1 is tethered to the membrane. The
fluorescence signal of mVenus-PRG after one minute of blue light illumination
was normalized to that before illumination. n>15. mean ± s.e.m. *** p<0.001 [
there is no single asterisks on the figure.
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Figure 48. Plexin-B1-RBD is a regulatory switch for PDZ-RhoGEF recruitment.
(a) Relative co-recruitment of PRG by optoPlexin, optoPlexin-GGA and
optoPlexin-L1799F with or without overexpression of ca-Rac1. (b) Relative
co-recruitment of PRG by optoPlexin mutants. n>15. mean ± s.e.m. ***
p<0.001, * p<0.05.
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whether the PBD alone is sufficient for PRG recruitment, we developed a
construct with the C-terminal 10 residues of Plexin-B1 tethered to Cry2
(optoPlexin-PBD, figure 21). We reasoned that if Rac1 binding exposed a cryptic
PBD, then optoPlexin-PBD ought to efficiently recruit PRG. We found that
optoPlexin-PBD fail to recruit PRG (Figure 48b). Additional interactions between
the PDZ domain of PRG and the RasGAP domain of B-plexins have been
proposed to stabilize PDZ binding178. Nevertheless, tethering the 20 C-terminal
residues of Plexin-B1, which included the additional interaction sites with PDZ
domain (Figure 21), to Cry2 did not significantly rescue the recruitment of PRG
(Figure 48b). It is likely that the PBD requires an intact RasGAP domain to
stabilize the extended binding interface with PDZ and the above isolated PBDs
may not be sufficient. Although crystal structures of B-family plexins did not
indicate a cryptic PBD, the PBD could be cryptic in cells in the presence of other
proteins. To investigate whether caRac1 binding affects the Plexin-B1-PDZ
interaction, we utilized the PDZ domain of PRG (Figure 45) in the co-recruitment
assay. Unexpectedly, co-expression of caRac1 did not promote recruitment of
the PDZ domain (Figure 49a). Moreover, optoPlexin-GGA and optoPlexinL1799F showed recruitment of PDZ domain not statistically different from the WT
optoPlexin (Figure 49b). These data indicated that Rac1 promotion of PRG
recruitment was not effected through increased PBD-PDZ binding.
Our data indicated that the PBD interaction, although necessary, was not
sufficient for robust recruitment of PRG by Plexin-B1, suggesting that there might
be additional interactions between Plexin-B1 and PRG. In both PRG and LARG
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the N-terminal PDZ domain is followed by an RGS-like domain, catalytic DH-PH
domain and an extended C-terminus. Particularly, the C-terminus and the RGSlike domain of PRG have been reported to mediate protein-protein interactions.
The extended C-terminus of PRG and LARG mediates homo and heterooligomerization between PRG, LARG and p115-RhoGEF and may play a role in
oncogenic transformation179. Furthermore, a proline-rich region in the C-terminus
of PRG has been reported to bind with the SH3 domain of Phospholipase C–γ,
whose SH2 domains bind to phosphorylated tyrosine residues in Plexin-B1149.
We have previously shown that the tyrosine residues that mediate interaction
with Phospholipase-Cγ are not critical for PRG recruitment by optoPlexin, RhoA
activation, or optoPlexin mediated repulsion in migrating cells (Figure 26g, 28,
35). Furthermore, the proline-rich sequences in PRG are not conserved in LARG,
further suggesting that these sequences are not critical for Rac1 mediated
increase in PRG and LARG recruitment. The RGS-like domain is utilized by Gα12
and Gα13 components of G-protein coupled receptors to recruit PRG, LARG and
p115-RhoGEF. However unlike those of p115-RhoGEF and LARG, the RGS-like
domain of PRG lacks GAP activity for Gα12 and Gα13180. Unlike the PDZ domain,
optoPlexin did not efficiently recruit the RGS-like domain of PRG (Figure 45)
indicating that if present, any direct interactions with Plexin-B1 are significantly
weaker than the Plexin-B1-PDZ binding or require PDZ domain interaction
(Figure 50b,c). To investigate whether in the presence of the PDZ domain the
RGS-like domain might mediate recruitment by Plexin-B1, we utilized the PDZRGS domains in recruitment assay (Figure 45). The PDZ-RGS domain was
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efficiently recruited by optoPlexin, and co-expression of caRac1 increased the
recruitment levels (Figure 49c). Moreover, optoPlexin-GGA failed to recruit PDZRGS domains whereas optoPlexin-L1799F showed very efficient recruitment
levels, comparable to recruitment by optoPlexin in the presence of caRac1
(Figure 49d). Thus the PDZ-RGS domain recapitulated the Rac1 regulation of
PRG recruitment indicating a role of RGS domain in Plexin-B1-PRG interaction.
The RGS-like domain of PRG interacts with GTP-loaded Gα13 through two
distinct sites, which are conserved in LARG and p115-RhoGEF174. We
speculated that these sites might also play a role in PRG recruitment by PlexinB1. To investigate this possibility we introduced a mutation in the RGS-box
subdomain of the RGS-like domain of PRG (L467Q) (Figure 45) to disrupt
interaction with Ras-like domain of Gα12 and Gα13. To validate the mutation, we
tethered a constitutive mutant of Gα12 to Cry2 (Cry2-Gα12) and utilized it for in-cyto
recruitment of PRG and its sub-domains. Cry2-Gα12 efficiently recruited PRG, as
well as the RGS-like domain, but not the PDZ domain of PRG (Figure 50a,b,c)
demonstrating that Cry2-Gα12 interacted with PRG similar to GTP-loaded Gα12
and Gα13. In addition, Cry2-Gα12 did not show any defects in recruitment of
PRG(V106E), suggesting that the PDZ domain does not significantly contribute
to association of PRG with Gα12 (Figure 50d). As expected Cry2-Gα12 failed to
recruit PRG(L467Q), thus validating the efficacy of the mutation. OptoPlexin
failed to recruit PRG(L467Q). These data further supported an inhibitory role of
the RGS-like domain in PDZ-PBD interaction (Figure 51).
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Figure 49. Rac1 regulation of PDZ-RhoGEF recruitment by Plexin-B1 is effected by
the RGS domain. Relative co-recruitment of (a) PDZ domain and (c) PDZ-RGS domain
by optoPlexin with or without overexpression of ca-Rac1. Relative co-recruitment of
(b) PDZ domain and (d) PDZ-RGS domain by optoPlexin, optoPlexin-GGA and
optoPlexin-L1799F. n>15. mean ± s.e.m. *** p<0.001, * p<0.05.
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Discussion and future directions: B family plexins utilize their C-terminal PBD
to recruit PRG and LARG through what was thought to be a constitutive
interaction with the PDZ domain of these RhoGEFs68. Our data suggests that
PBD-PDZ interaction between Plexin-B1 and PRG is not constitutive, and is
regulated by GTPase binding to Plexin-RBD. Lack of recruitment of PRG by
optoPlexin-PBD indicated that the canonical PBD-PDZ interaction is not sufficient
for efficient PRG recruitment, which is consistent with the low affinity (~ 30 μM) of
bindng between PBD and PDZ domain178. Additional interactions between the
RasGAP domain and the PDZ domain have been reported to significantly boost
the affinity between Plexin-B1 and PDZ domain ( to ~ 3 μM). This is reflected in
our data wherein unlike optoPlexin, optoPlexin-PBD failed to efficiently recruit
PRG. Regardless, these additional PDZ interactions do not explain why coexpression of caRac1 promoted recruitment of PRG and PDZ-RGS, but not of
the PDZ domain alone. GTPase binding to Plexin-B1 is known to mediate its
RasGAP activity63. Our data demonstrate a role of GTPase binding in RhoGEF
recruitment. Furthermore, optoPlexin-GGA, which contains all the identified
interaction sites between PDZ domain and PRG, recruited the PDZ domain
efficiently, but not PRG or PDZ-RGS. Finally, mutating one of the known
interaction sites between PRG-RGS-like domain and Gα12/13 abrogated PRG
recruitment by optoPlexin. Taken together, these observations suggest a model
where the RGS-like domain hinders PDZ-binding, through direct obstruction of
the PBD-interaction or through allosteric inhibition (Figure 51). This obstruction is
presumably relieved through some hitherto unknown interaction with Plexin-B1,
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which is mediated by the Plexin-B1-RBD. Truncation of the RBD did not impact
PRG or PDZ-RGS recruitment suggesting that it did not directly associate with
the RGS domain. Since truncation of the juxtamembrane helix also did not
impact PRG recruitment levels, we hypothesize that the RGS-like domain
interacts with the RasGAP domain of Plexin-B1. Lack of efficient recruitment of
the RGS-like domain with optoPlexin or any of its mutants suggests that the
interaction is significantly weaker than that with PDZ domain. A pull-down assay
might be appropriate to examine any interactions between purified Plexin-B1 (or
its mutants) intracellular domain and the RGS-like domain of PRG. It is, of
course, possible that Gα12 or Gα13 might co-operate with the Plexin-B1 signaling
complex to respectively bind to the RGS-like and PDZ domain. Failure of
optoPlexin in recruiting PRG(V106E) suggests that any association of the PlexinB1 complex with the RGS domain is significantly weaker than the PDZ-PBD
interaction, which is weaker than Gα12 or Gα13 association with RGS domain. This
argues against a role of Gα12 or Gα13 GTPases in Plexin-B1 recruitment of PRG,
since even in the absence of PDZ-PBD interaction, Gα12 or Gα13 associated with
optoPlexin should have been able to recruit PRG(V106E).
Recently, Plexin-D1 has been reported to bind to GIPC1 (GAIP interacting
protein, C-terminus 1) through the C-terminal PBD of Plexin-D1 and PDZ domain
of GIPC1181. In the native state, GIPC1 exists in a dimerized state where the
GH1 and GH2 domains that flank the PDZ domain inhibit interaction with PlexinD1 C-terminal PBD. Our observations suggesting an inhibitory role of the RGSlike domain in mediating PDZ-PBD interaction appears, at least superficially, to
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be similar in nature and might be another mode of conferring specificity to PDZPBD interactions. Investigating mechanisms that regulate interactions between
other PDZ domain and PBD containing proteins might yield hints about Plexin-B1
and PRG regulation as well. GTPase binding does not significantly alter the
conformation of the isolated Plexin-RBD182. Such binding may, however, relieve
autoinhibition of the Plexin RasGAP domain by facilitating oligomerization
wherein the RBD no longer blocks interaction between the RasGAP domain and
GTP-loaded Ras or Rap proteins. GTPase binding may also induce
conformational changes in the RasGAP domain to promote or stabilize its binding
to small GTPases. Whether the same residues in the Plexin-B1 RasGAP domain
might regulate interaction between small GTPases and PRG remains
unexplored. While the plexins show remarkable homology in their intracellular
domains, there are subtle differences that might explain their specificities for
different Rho and Ras GTPases. In particular, all plexins have a conserved
leucine residue (L1658 in Plexin-B1) in the RasGAP region that might directly
interact with the GTP in GTP-loaded Ras or Rap proteins. In A family plexins, the
L1658 residue is exposed to freely interact with GTP. However in B family
plexins, a conserved tyrosine residue (Y1651 in Plexin-B1) appears to interact
with L1658, and might regulate its interaction with GTP-Ras. Substituting the
amino acid sequence in Plexin-B1 that spans through Y1651 with the
corresponding sequence in Plexin-A1 and investigating PRG recruitment by the
resultant protein might provide information regarding the role of these sites in
PRG recruitment. If this indeed were the site of additional PRG interaction, it
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would be interesting to examine whether GTP-Ras and PRG binding to Plexin-B1
are competitive or co-operative.
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Materials and methods:
Cell culture and transfection. All the experiments in chapter II were performed
on COS7 cells. COS-7 cells were obtained from American Type Culture
Collection (ATCC) and were cultured in DMEM (Lonza, Basel, Switzerland) basal
media, and were passaged every third day of culture. For optimal growth, the
media were supplemented with 10% (v/v) FBS (Gibco, Billings, MO) and
Penicillin/Streptomycin (Lonza), and the cells were maintained under standard
cell culture conditions (37°C and 5% CO2). The cell lines were regularly checked
for mycoplasma contamination. FuGENE 6 reagent (Promega, Madison, WI) was
used for transient transfections according to manufacturer’s instructions.
DNA plasmids. psd44-G12QL (caGα12) was a gift from Agnese Mariotti (Addgene
plasmid # 46825). OptoPlexin and optoPlexin mutants, PRG and LARG plasmids
were generated as described in the materials and methods section of chapter II.
Additional optoPlexin and PRG mutants were generated using overlapping
polymerase chain reaction (PCR). Cry2-caRac1 and Cry2-caGα12 were designed in
a manner similar to optoPlexin. Briefly, Cry2 was positioned at the N-terminus and
caRac1 or caGα12 at the C-terminus. For the co-recruitment assay, Cry2 plasmids
were tethered to mCherry and RhoGEF plasmids were tethered to mVenus. These
constructs were initially subcloned into the pTriEx-4 vector (Novagen) using PCR
and restriction digestion. Unless specified otherwise, the termini of tagging were
positioned as in the orders they were written. The open reading frames of all DNA
plasmids were verified by DNA sequencing.
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Imaging setup. All time-lapse imaging were performed on a customized Nikon
Ti-E inverted microscope. TIRF imaging was performed using a 60x oil TIRF
objective (NA 1.49). The microscope was modified with a “stage-up” design
which enables an insertion of two independent, motorized dichroic mirrors/filter
cubes in the microscope infinity space. A dichroic mirror in the bottom cube was
used to reflect excitation laser lines at 442, 514, 594 nm for imaging of
mCerulean, mVenus, and mCherry respectively. The laser lines were launched
from a fiber-coupled LMM5 system (Andor) equipped with an acousto-optic
tunable filter (AOTF) for shutter and intensity control. Another dichroic mirror
(495LP) in the top cube was used to bring in optogenetic illumination originated
from a LED source at 440 nm (CoolLED). The 495LP mirror permitted immediate
acquisition of mVenus or mCherry after optogenetic illumination. Alternatively,
the top mirror can be rotated out to a blank position for Patterned illumination
was generated using a commercial digital mirror device (Mosaic, Andor). The
fluorescent emission was captured with an EMCCD camera (iXon Ultra, Andor).
Metamorph software was used to control the imaging set up. Live cell imaging
was performed at 37°C in a heated chamber (Bioptechs) with humidified 5% CO2
supply. Vitamin and phenol red-free media (US Biological) supplemented with
2% FBS were used in imaging to reduce background and photobleaching.
Membrane recruitment assay. Co-recruitment of PRG and its variants by
optoPlexin and it variants, and Cry2-Gα12 were assessed as described in Chapter
II. Activation of paRac1 does not involve any membrane translocation. So,
recruitment levels of PRG by Cry2-caRac1 and paRac1 were assessed by the
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change in TIRF intensity of mVenus (tethered to PRG) after 100 seconds of blue
light illumination relative to that before illumination.
Statistical analyses. Microsoft Excel and Matlab were used for statistical
analyses. Sample sizes for different experiments were chosen based on the
commonly used range in the field without conducting any statistical power
analysis. Normal probability plot function of Matlab was utilized to confirm normal
distribution of the data. Sample means and standard error of mean was
calculated and shown on the graphs. P values were obtained from one-tailed
Students t-test.
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Chapter IV
General discussion and future directions
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Spatial and temporal regulation is fundamental for coordination of signaling
pathways that mediate physiological phenomena. Dysregulation of either can lead
to development of pathologies. In this work, we investigated coordination of
osteoblast migration by osteoclasts upon direct contact between the cells and
elucidated spatiotemporal regulation of pathways that mediate resulting osteoblast
response.
Further roles of CIL in bone remodeling. Bone remodeling is initiated by
migration of osteoclasts to a site with damaged bone matrix and start resorption.
How osteoclasts identify and migrate to these sites is a topic of extensive research,
and is beyond the scope of this work. Osteoclasts are derived from hematopoietic
lineage progenitors that differentiate towards macrophage-monocytic lineage upon
exposure to macrophage-colony stimulating factor (MCSF), which is expressed by
osteoblast lineage cells. While full-length MCSF precursor is membrane-tethered,
the extracellular domain may be proteolytically cleaved to produce a soluble
cytokine. These ‘pre-osteoclasts’ must come in contact with osteoblastic cells for
RANKL stimulation, which is necessary for osteoclastogenesis. RANKL stimulates
Sema4D expression in pre-osteoclasts, and this event may initiate the segregation
of osteoblastic and osteoclastic cells, which persists through the rest of the bone
remodeling cycle. Drosophila macrophages have been reported to undergo
homotypic CIL37,56, which facilitates its spread through the animal body. If
osteoclast precursors also undergo similar homotypic CIL, either MCSFor RANKL
stimulation may be expected to downregulate the factors that mediate such CIL,
since homotypic CIL may render the fusion of the pre-osteoclasts very inefficient.
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In addition to Plexin-B1 and Plexin-B2, osteoblastic cells also
express their ligand, Sema4D15. The role of osteoblastic Sema4D in its motility and
function is not understood. It is conceivable that homotypic CIL between
osteoblasts may facilitate collective migration. In addition, Sema4D from
osteoblasts undergoing collective motion may also act to keep the cells in a
relatively undifferentiated state until the target site has been reached. Since
Sema4D extracellular domain may be cleaved to obtain a soluble ligand183, it may
also act as a decoy ligand to compete against Sema4D expressed by other cells in
the bone microenvironment. However the significance of Sema4D expressed by
osteoblasts in migration and differentiation in vivo remains to be further
investigated.
Spatial regulation of β-Pix in cell repolarization. In chapter II, we
demonstrated spatial regulation of β-Pix in osteoblastic cells undergoing
repolarization. β-Pix associates with Paxilin in adhesions through Git-1184. Our data
suggest that β-Pix association with focal adhesions is negatively responsive to
mechanical tension. To test whether β-Pix or Git1 responds to mechanical tension,
we treated MC3T3-E1 cells expressing mCherry-Paxilin and mVenus-Git1 with Y27632 ROCK inhibitor. Unlike β-Pix, Git1 showed a decrease in association with
adhesions (Figure 52a). These data suggest that in response to RhoA-ROCK
signaling, β-Pix dissociates from the Git1-Paxilin complex (Figure 52b), which in
turn suggests that there might be a change in the state of either β-Pix or Git1
downstream of ROCK signaling. Indeed, if β-Pix redistribution during CIL is
mediated by mechanical tension, our data would suggest the presence of a
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mechanosensitive element in either β-Pix or Git1, which directly responds to
mechanical tension, or acts as a substrate to another enzyme that does. Further
investigation into the signaling pathways that mediate β-Pix dissociation from Git1Paxilin complex may provide interesting insight into how cells respond to
mechanical tension.
Rac1 regulation of RhoGEF recruitment by Plexin-B1. Our data on the
effect of GTP-loaded Rac1 on facilitating PRG recruitment by Plexin-B1
demonstrates a role of Plexin-B1 in integrating extracellular and intracellular
signals to modulate cell response to its environment. Rac1 promotes actin
polymerization and protrusions. By regulating PRG recruitment and activation by
Plexin-B1, Rac1 provides a distinct spatial control of Plexin-B1, presumably
localizing it to active protrusions, and minimizing any impact of Sema4D
stimulation in non-protruding regions in a cell. Additionally, Rac1 and RhoA are
generally thought to inhibit one another55. Thus, in Sema4D-Plexin-B1 signaling,
Rac1 may act as a switch to rapidly convert a region of high Rac1 and low RhoA
activity to one of high RhoA and low Rac1 activity. Such a change may facilitate
rapid induction of CIL, enabling cells to efficiently respond to extracellular cues.
Our data implicates the RGS domain of PRG in Rac1 regulation of Plexin-B1
signaling. This provides an interesting intersection of signaling cascades initiated
by heterotrimeric G proteins and Plexins. Whether these two pathways compete for
available RhoGEFs in a cell remains to be investigated. Although the exact
mechanism by which PRG or LARG is activated by either pathways is not
completely understood. Although mere plasma membrane recruitment of PRG may
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be sufficient for activation185, such recruitment clearly involves the RGS domain.
Further investigation of both plexins and G-protein signaling may help elucidate the
molecular mechanism of PRG and LARG activation.
In chapter II, I investigated the underlying signaling pathways that mediate
spatial segregation of osteoblasts and osteoclasts in vivo. Using a co-culture
system, I have demonstrated that osteoblasts undergo CIL upon contact with
osteoclasts. Applying gene editing techniques, I have established a role of PlexinB1 signaling in mediating said CIL, and by utilizing an optogenetic tool I have
demonstrated that localized activation of Plexin-B1 signaling is capable of
recapitulating the CIL-like behavior that osteoblasts exhibit upon contact with
osteoclasts. The stark contrast between a collapse phenotype upon whole cell
stimulation and cell repolarization upon localized stimulation underscores the
necessity of investigating spatial regulation of signaling pathways to better
understand their roles in cell behavior. Since Plexins show remarkable homology in
their intracellular domains, the design for optoPlexin, pertinent to Plexin-B1, should
be extendable to other plexins as well. In chapter III, I have explored the regulation
of Plexin-B1 signaling by GTP-Rac1 association with Plexin-B1-RBD. Utilizing a
co-recruitment assay of PRG with optoPlexin, I have demonstrated that GTP-Rac1
association with Plexin-B1 mediates PRG recruitment. Utilizing various mutations
of optoPlexin and PRG, I have identified a role of the RGS domain of PDZRhoGEF in Plexin-B1-PRG association. Overall, these new findings increase our
understanding of the nature of interactions between osteoclasts and osteoblasts,
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the role of Plexin-B1 signaling and spatiotemporal regulation of other signaling
molecules in CIL, and molecular mechanisms that mediate Plexin signaling.
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List of movies:
Movie 1: Spatial segregation between an osteoclast and primary osteoblasts.
Primary murine calvarial osteoblasts were co-cultured with murine osteoclasts and
imaged using phase contrast at 5 minute intervals. Scale bar, 50 μm.
Movie 2: Osteoblast undergoing CIL on contact with osteoclast. Primary
murine calvarial osteoblasts migrating towards murine osteoclasts were imaged
using phase contrast at 5 minute intervals. Scale bar, 50 μm.
Movie 3: MC3T3-E1 cell undergoing CIL on contact with osteoclast. MC3T3E1 osteoblastic cells migrating towards murine osteoclasts were imaged using
phase contrast at 5 minute intervals. Scale bar, 50 μm.
Movie 4: MC3T3-E1 cell on contact with a bone marrow macrophage. MC3T3E1 osteoblastic cells migrating towards murine BMMs were imaged using phase
contrast at 5 minute intervals. Scale bar, 50 μm.
Movie 5: Cas9 MC3T3-E1 cell undergoing CIL on contact with osteoclast.
Cas9 expressing MC3T3-E1 cells encountering murine osteoclasts were imaged
using phase contrast at 2 minute intervals. Scale bar, 50 μm.
Movie 6: KO1 MC3T3-E1 cell CIL on contact with osteoclast. Plexin-B1 null
KO1 MC3T3-E1 cells migrating towards murine osteoclasts were imaged using
phase contrast at 2 minute intervals. Scale bar, 50 μm.
Movie 7: KO2 MC3T3-E1 cell CIL on contact with osteoclast. Plexin-B1 null
KO2 MC3T3-E1 cells were co-cultured with murine osteoclasts and imaged using
phase contrast at 2 minute intervals. Scale bar, 50 μm.
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Movie 8: Clustering of Plexin-B1-mCherry around Sema4D-Fc silica beads.
COS-7 cells were transfected with Plexin-B1-mCherry and Sema4D-Fc silica
beads were added to the culture. Contact between the beads and the cells, and
subsequent changes in mCherry fluorescence distribution were observed using
using 60X objective at 1 minute intervals. Scale bar, 10 μm.
Movie 9: Translocation of optoPlexin to the plasma membrane upon blue
light illuminaton. The fluorescence intensities of mCherry-optoPlexin or mCherryoptoPlexin(D393A) in COS-7 cells were imaged using TIRFM upon whole cell
illumination at 440 nm and at 10 second intervals. The cells were coexpressing
CIB-mEGFP-CAAX. Scale bar, 10 μm.
Movie 10: Corecruitment of PRG with optoPlexin upon whole cell
illumination. Representative TIRF images showing simultaneous changes in
membrane intensity of mCherry-optoPlexin and mVenus-PRG in COS-7 cells upon
whole cell illumination with 440 nm light at 10 second intervals. The COS-7 cells
were transiently expressing CIB-CAAX, mCherry-optoPlexin and mVenus-PRG.
Timestamp shows minutes and seconds post illumination. Scale bar, 10 μm.
Movie 11: Induction of CIL upon local activation of optoPlexin. DIC and TIRF
images showing local activation of mCherry-optoPlexin and subsequent induction
of CIL in MC3T3-E1 cells. mEGFP-CIB-CAAX and mCherry-optoPlexin were
transiently expressed in MC3T3-E1 cells and in one such migrating cell, mCherryoptoPlexin was stimulated at a protrusion using localized 440 nm light illumination
at 10 second intervals. Timestamp shows minutes and seconds post illumination.
Magenta circle, region of illumination (diameter, 5 μm). Scale bar, 10 μm.
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Movie 12: Local optoPlexin stimulation induces change in direction in a
migrating cell. DIC and TIRF images showing local activation of mCherryoptoPlexin and subsequent change in direction of migration in MC3T3-E1 cells.
CIB-CAAX and mCherry-optoPlexin were transiently expressed in MC3T3-E1 cells
and mCherry-optoPlexin was stimulated at a protrusion using localized 440 nm
light illumination at 20 second intervals. Timestamp shows minutes and seconds
post illumination. Magenta circle, region of illumination (diameter, 5 μm). Scale bar,
10 μm.
Movie 13: Local stimulation of optoPlexin-delPBD. DIC and TIRF images
showing local accumulation of mCherry-optoPlexin-delPBD but no induction of CIL
in a MC3T3-E1 cell. mEGFP-CIB-CAAX and mCherry-optoPlexin-delPBD were
transiently expressed in MC3T3-E1 cells. OptoPlexin-delPBD was stimulated at a
protrusion using localized 440 nm light illumination at 10 second intervals.
Timestamp shows minutes and seconds post illumination. Magenta circle, region of
illumination (diameter, 5 μm). Scale bar, 10 μm.
Movie 14: Induction of cell collapse upon whole cell activation of optoPlexin.
DIC and TIRF images showing activation of mCherry-optoPlexin and subsequent
morphological changes in MC3T3-E1 cells upon stimulation using 440 nm light
illumination at 10 second intervals throughout the field of view. The MC3T3-E1
cells were transiently expressing mEGFP-CIB-CAAX and mCherry-optoPlexin.
Timestamp shows minutes and seconds post illumination. Scale bar, 10 μm.
Movie 15: Co-recruitment of PRG with optoPlexin upon local illumination.
TIRF images showing changes in membrane intensity of mCherry-optoPlexin and
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mVenus-PRG upon localized illumination (as indicated by white arrowhead) with
440 nm light at 10 second intervals. MC3T3-E1 cells were transiently expressing
CIB-CAAX, mCherry-optoPlexin and mVenus-PRG. Timestamp, minutes after
illumination. Scale bar, 10 μm.
Movie 16: Polarized distribution of MyoRLC upon local optoPlexin activation.
TIRF images showing localized activation of mVenus-optoPlexin and subsequent
changes in mCherry-MyoRLC distribution. CIB-CAAX, mVenus-optoPlexin and
mCherry-myoRLC were transiently expressed in MC3T3-E1 cells. mCherryOptoPlexin was stimulated at a protrusion using localized 440 nm light illumination
at 10 second intervals. Timestamp shows minutes and seconds post illumination.
Magenta circle, region of illumination (diameter, 5 μm). Scale bar, 10 μm.
Movie 17: Local stimulation of optoPlexin-RA. DIC and TIRF images showing
local accumulation of mCherry-optoPlexin-RA but no induction of CIL in a MC3T3E1 cell. mEGFP-CIB-CAAX and mCherry-optoPlexin-delPBD were transiently
expressed in MC3T3-E1 cells. OptoPlexin-RA was stimulated at a protrusion using
localized 440 nm light illumination at 10 second intervals. Timestamp shows
minutes and seconds post illumination. Magenta circle, region of illumination
(diameter, 5 μm). Scale bar, 10 μm.
Movie 18: Local stimulation of optoPlexin-YF. DIC and TIRF images showing
local activation of mCherry-optoPlexin-YF and subsequent induction of CIL in
MC3T3-E1 cells. CIB-CAAX and mCherry-optoPlexin were transiently expressed in
MC3T3-E1 cells and in one such migrating cell, mCherry-optoPlexin-YF was
stimulated at a protrusion using localized 440 nm light illumination at 10 second
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intervals. Timestamp shows minutes and seconds post illumination. Magenta
circle, region of illumination (diameter, 5 μm). Scale bar, 10 μm.
Movie 19: Mobilization and redistribution of β-Pix upon local activation of
optoPlexin. TIRF images showing redistribution of mVenus-β-Pix upon localized
activation of mCherry-optoPlexin in a MC3T3-E1 cell. CIB-CAAX, mCherryoptoPlexin and mVenus-β-Pix were transiently expressed in MC3T3-E1 cells.
mVenus-optoPlexin was stimulated at a protrusion using localized 440 nm light
illumination at 10 second intervals. Timestamp shows minutes and seconds post
illumination. Magenta circle, region of illumination (diameter, 5 μm). Scale bar, 10
μm.
Movie 20: Effects of local activation of optoPlexin on adhesions. TIRF images
showing changes in mCherry-Paxillin distribution upon localized activation of
mVenus-optoPlexin in a MC3T3-E1 cell. CIB-CAAX, mVenus-optoPlexin and
mCherry-Paxillin were transiently expressed in MC3T3-E1 cells. mVenusoptoPlexin was stimulated at a protrusion using localized 440 nm light illumination
at 10 second intervals. Timestamp shows minutes and seconds post illumination.
Magenta circle, region of illumination (diameter, 5 μm). Scale bar, 10 μm.
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